Regulation	O
of	O
granulocyte-macrophage	B-protein
colony-stimulating	I-protein
factor	I-protein
and	O
E-selectin	B-protein
expression	O
in	O
endothelial	B-cell_type
cells	I-cell_type
by	O
cyclosporin	O
A	O
and	O
the	O
T-cell	B-protein
transcription	I-protein
factor	I-protein
NFAT	B-protein
.	O

Nuclear	B-protein
factor	I-protein
of	I-protein
activated	I-protein
T	I-protein
cells	I-protein
(	O
NFAT	B-protein
)	O
was	O
originally	O
described	O
as	O
a	O
T-cell-specific	B-protein
transcription	I-protein
factor	I-protein
athat	O
supported	O
the	O
activation	O
of	O
cytokine	B-protein
gene	O
expression	O
and	O
mediated	O
the	O
immunoregulatory	B-protein
effects	O
of	O
cyclosporin	O
A	O
(	O
CsA	O
)	O
.	O

As	O
we	O
observed	O
that	O
activated	B-cell_type
endothelial	I-cell_type
cells	I-cell_type
also	O
expressed	O
NFAT	B-protein
,	O
we	O
tested	O
the	O
antiinflammatory	O
properties	O
of	O
CsA	O
in	O
endothelial	B-cell_type
cells	I-cell_type
.	O

Significantly	O
,	O
CsA	O
completely	O
suppressed	O
the	O
induction	O
of	O
NFAT	B-protein
in	O
endothelial	B-cell_type
cells	I-cell_type
and	O
inhibited	O
the	O
activity	O
of	O
granulocyte-macrophage	B-DNA
colony-stimulating	I-DNA
factor	I-DNA
(	I-DNA
GM-CSF	I-DNA
)	I-DNA
gene	I-DNA
regulatory	I-DNA
elements	I-DNA
that	O
use	O
NFAT	B-protein
by	O
60	O
%	O
.	O

CsA	O
similarly	O
mediated	O
a	O
reduction	O
of	O
up	O
to	O
65	O
%	O
in	O
GM-CSF	B-RNA
mRNA	I-RNA
and	O
protein	O
expression	O
in	O
activated	B-cell_type
endothelial	I-cell_type
cells	I-cell_type
.	O

CsA	O
also	O
suppressed	O
E-selectin	B-protein
,	O
but	O
not	O
vascular	B-protein
cell	I-protein
adhesion	I-protein
molecule-1	I-protein
(	O
VCAM-1	B-protein
)	O
expression	O
in	O
endothelial	O
cells	O
,	O
even	O
though	O
the	O
E-selectin	B-DNA
promoter	I-DNA
is	O
activated	O
by	O
NF-kappa	B-protein
B	I-protein
rather	O
than	O
NFAT	B-protein
.	O

Hence	O
,	O
induction	O
of	O
cell	O
surface	O
expression	O
of	O
this	O
leukocyte	B-protein
adhesion	I-protein
molecule	I-protein
by	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
(	I-protein
TNF	I-protein
)	I-protein
-alpha	I-protein
was	O
reduced	O
by	O
40	O
%	O
in	O
the	O
presence	O
of	O
CsA	O
,	O
and	O
this	O
was	O
reflected	O
by	O
a	O
29	O
%	O
decrease	O
in	O
neutrophil	B-cell_type
adhesion	O
.	O

The	O
effects	O
of	O
CsA	O
on	O
endothelial	B-cell_type
cells	I-cell_type
were	O
also	O
detected	O
at	O
the	O
chromatin	B-DNA
structure	O
level	O
,	O
as	O
DNasel	B-DNA
hypersensitive	I-DNA
sites	I-DNA
within	O
both	O
the	O
GM-CSF	B-protein
enhancer	O
and	O
the	O
E-selectin	B-DNA
promoter	I-DNA
were	O
suppressed	O
by	O
CsA	O
.	O

This	O
represents	O
the	O
first	O
report	O
of	O
NFAT	B-protein
in	O
endothelial	B-cell_type
cells	I-cell_type
and	O
suggests	O
mechanisms	O
by	O
which	O
CsA	O
could	O
function	O
as	O
an	O
antiinflammatory	O
agent	O
.	O

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

Regulation	NULL
of	NULL
Granulocyte-	NULL
Macrophage	NULL
Colony-Stimulating	NULL
Factor	NULL
and	NULL
E-Selectin	NULL
Expression	NULL
in	NULL
Endothelial	NULL
Cells	NULL
by	NULL
Cyclosporin	NULL
A	NULL
and	NULL
the	NULL
T-Cell	NULL
Transcription	NULL
Factor	NULL
NFAT	NULL
By	NULL
Gillian	NULL
W.	NULL
Cockerill	NULL
,	NULL
Andrew	NULL
G.	NULL
Bert	NULL
,	NULL
Gregory	NULL
R.	NULL
Ryan	NULL
,	NULL
Jennifer	NULL
R.	NULL
Gamble	NULL
,	NULL
Mathew	NULL
A.	NULL
Vadas	NULL
,	NULL
and	NULL
Peter	NULL
N.	NULL
Cockerill	NULL
Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
was	NULL
originally	NULL
described	NULL
as	NULL
a	NULL
T-cell-specific	NULL
transcription	NULL
factor	NULL
that	NULL
supported	NULL
the	NULL
activation	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
and	NULL
mediated	NULL
the	NULL
immunoregulatory	NULL
effects	NULL
of	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
.	NULL

As	NULL
we	NULL
observed	NULL
that	NULL
activated	NULL
endothelial	NULL
celis	NULL
also	NULL
expressed	NULL
NFAT	NULL
,	NULL
we	NULL
tested	NULL
the	NULL
antiinflammatory	NULL
properties	NULL
of	NULL
CsA	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Significantly	NULL
,	NULL
CsA	NULL
completely	NULL
suppressed	NULL
the	NULL
induction	NULL
of	NULL
NFAT	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
inhibited	NULL
the	NULL
activity	NULL
of	NULL
granulocyte-	NULL
macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
gene	NULL
regulatory	NULL
elements	NULL
that	NULL
use	NULL
NFAT	NULL
by	NULL
60	NULL
%	NULL
.	NULL

CsA	NULL
similarly	NULL
mediated	NULL
a	NULL
reduction	NULL
of	NULL
up	NULL
to	NULL
65	NULL
%	NULL
in	NULL
GM-CSF	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
activated	NULL
endothelial	NULL
cells	NULL
.	NULL

CsA	NULL
also	NULL
suppressed	NULL
E-selectin	NULL
,	NULL
but	NULL
not	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
VCAM-1	NULL
)	NULL
expression	NULL
in	NULL
HE	NULL
REGULATION	NULL
of	NULL
cytokine	NULL
gene	NULL
expression	NULL
is	NULL
central	NULL
to	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
immune	NULL
response	NULL
.	NULL
``	NULL

''	NULL
The	NULL
T	NULL
cell	NULL
has	NULL
been	NULL
the	NULL
most	NULL
intensively	NULL
studied	NULL
model	NULL
system	NULL
for	NULL
investigating	NULL
cytokine	NULL
gene	NULL
regulation	NULL
,	NULL
as	NULL
a	NULL
wide	NULL
variety	NULL
of	NULL
cytokines	NULL
are	NULL
induced	NULL
on	NULL
activation	NULL
of	NULL
the	NULL
T-cell	NULL
receptor	NULL
.	NULL
``	NULL

The	NULL
transcription	NULL
factor	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NFAT	NULL
)	NULL
*	NULL
plays	NULL
a	NULL
key	NULL
role	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
many	NULL
of	NULL
these	NULL
genes	NULL
and	NULL
is	NULL
itself	NULL
induced	NULL
on	NULL
T-cell	NULL
receptor	NULL
activation	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
interleukin-2	NULL
(	NULL
IL-2	NULL
)	NULL
and	NULL
granulocyte-macrophage	NULL
-	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
GM-CSF	NULL
)	NULL
in	NULL
T	NULL
cells	NULL
can	NULL
be	NULL
suppressed	NULL
by	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
,	NULL
and	NULL
these	NULL
effects	NULL
are	NULL
largely	NULL
caused	NULL
by	NULL
the	NULL
ability	NULL
of	NULL
CsA	NULL
to	NULL
inhibit	NULL
activation	NULL
of	NULL
NFAT	NULL
.	NULL

'***~	NULL
Furthermore	NULL
,	NULL
the	NULL
immunosuppressive	NULL
actions	NULL
of	NULL
CsA	NULL
have	NULL
been	NULL
widely	NULL
attributed	NULL
to	NULL
its	NULL
ability	NULL
to	NULL
suppress	NULL
T-cell	NULL
expression	NULL
of	NULL
cytokines	NULL
such	NULL
as	NULL
IL-2	NULL
,	NULL
and	NULL
bence	NULL
T-cell	NULL
activation	NULL
and	NULL
proliferation	NULL
.	NULL

NFAT	NULL
,	NULL
initially	NULL
thought	NULL
to	NULL
be	NULL
a	NULL
T-cell	NULL
specific	NULL
factor	NULL
,	NULL
typically	NULL
consists	NULL
of	NULL
a	NULL
complex	NULL
of	NULL
AP-l	NULL
family	NULL
proteins	NULL
and	NULL
NFATp	NULL
or	NULL
NFATc	NULL
,	NULL
which	NULL
are	NULL
respectively	NULL
induced	NULL
via	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
Ca**	NULL
signals	NULL
originating	NULL
from	NULL
T-cell	NULL
receptor	NULL
activation.®	NULL
``	NULL
``	NULL
NFATp	NULL
and	NULL
NFATc	NULL
are	NULL
related	NULL
proteins*	NULL
``	NULL
that	NULL
are	NULL
expressed	NULL
in	NULL
the	NULL
cytoplasm	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
translocate	NULL
to	NULL
the	NULL
nucleus	NULL
in	NULL
response	NULL
to	NULL
the	NULL
Ca**	NULL
activation	NULL
of	NULL
the	NULL
CsA-inhibitible	NULL
phosphatase	NULL
calcineurin	NULL
.	NULL

**	NULL
``	NULL
``	NULL
``	NULL
Hence	NULL
,	NULL
NFATp	NULL
and	NULL
NFATc	NULL
are	NULL
major	NULL
targets	NULL
for	NULL
the	NULL
actions	NULL
of	NULL
CsA	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
genes	NULL
for	NULL
NFATp	NULL
and	NULL
NFATc	NULL
have	NULL
recently	NULL
been	NULL
cloned	NULL
``	NULL
and	NULL
it	NULL
is	NULL
now	NULL
believed	NULL
that	NULL
NFATc	NULL
is	NULL
largely	NULL
restricted	NULL
to	NULL
lymphoid	NULL
tissues	NULL
,	NULL
while	NULL
NFATp	NULL
expression	NULL
is	NULL
more	NULL
widespread	NULL
.	NULL

NFAT	NULL
contributes	NULL
to	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
locus	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
interacting	NULL
with	NULL
four	NULL
strong	NULL
binding	NULL
sites	NULL
in	NULL
an	NULL
upstream	NULL
enhancer®	NULL
``	NULL
and	NULL
two	NULL
weak	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
.	NULL
``	NULL

However	NULL
,	NULL
GM-CSF	NULL
is	NULL
also	NULL
expressed	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
in	NULL
many	NULL
cell	NULL
types	NULL
other	NULL
than	NULL
T	NULL
cells	NULL
.	NULL

>	NULL
``	NULL
This	NULL
raises	NULL
the	NULL
possibility	NULL
that	NULL
induction	NULL
of	NULL
GM-CSF	NULL
expression	NULL
in	NULL
these	NULL
cell	NULL
types	NULL
could	NULL
also	NULL
require	NULL
NFAT	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
GM-CSF	NULL
locus	NULL
may	NULL
also	NULL
be	NULL
a	NULL
target	NULL
for	NULL
CsA	NULL
in	NULL
cells	NULL
such	NULL
as	NULL
activated	NULL
endothelial	NULL
cells	NULL
that	NULL
express	NULL
GM-CSF	NULL
.	NULL

The	NULL
endothelial	NULL
cell	NULL
represents	NULL
the	NULL
interface	NULL
between	NULL
the	NULL
Blood	NULL
,	NULL
Vol	NULL
86	NULL
,	NULL
No	NULL
7	NULL
(	NULL
October	NULL
1	NULL
)	NULL
,	NULL
1995	NULL
:	NULL
pp	NULL
2689-2698	NULL
endothelial	NULL
cells	NULL
,	NULL
even	NULL
though	NULL
the	NULL
E-selectin	NULL
promoter	NULL
is	NULL
activated	NULL
by	NULL
NF-	NULL
«	NULL
B	NULL
rather	NULL
than	NULL
NFAT	NULL
.	NULL

Hence	NULL
,	NULL
induction	NULL
of	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
this	NULL
leukocyte	NULL
adhesion	NULL
molecule	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor	NULL
(	NULL
TNF	NULL
)	NULL
-a	NULL
was	NULL
reduced	NULL
by	NULL
40	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
,	NULL
and	NULL
this	NULL
was	NULL
reflected	NULL
by	NULL
a	NULL
29	NULL
%	NULL
decrease	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
CsA	NULL
on	NULL
endothelial	NULL
cells	NULL
were	NULL
also	NULL
detected	NULL
at	NULL
the	NULL
chromatin	NULL
structure	NULL
level	NULL
,	NULL
as	NULL
DNase	NULL
!	NULL

hypersensitive	NULL
sites	NULL
within	NULL
both	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
and	NULL
the	NULL
E-selectin	NULL
promoter	NULL
were	NULL
suppressed	NULL
by	NULL
CsA	NULL
.	NULL

This	NULL
represents	NULL
the	NULL
first	NULL
report	NULL
of	NULL
NFAT	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
suggests	NULL
mechanisms	NULL
by	NULL
which	NULL
CsA	NULL
could	NULL
function	NULL
as	NULL
an	NULL
antiinflammatory	NULL
agent	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

hematopoietic	NULL
compartment	NULL
where	NULL
immune	NULL
effector	NULL
cells	NULL
originate	NULL
and	NULL
tissues	NULL
where	NULL
primary	NULL
immune	NULL
responses	NULL
oc-cur	NULL
,	NULL
and	NULL
endothelial	NULL
cells	NULL
play	NULL
a	NULL
direct	NULL
role	NULL
in	NULL
governing	NULL
the	NULL
traffic	NULL
of	NULL
leukocytes	NULL
across	NULL
the	NULL
endothelium	NULL
.	NULL
``	NULL

On	NULL
activation	NULL
,	NULL
endothelial	NULL
cells	NULL
produce	NULL
numerous	NULL
cytokines	NULL
,	NULL
including	NULL
GM-CSF	NULL
,	NULL
which	NULL
activate	NULL
immune	NULL
response	NULL
effector	NULL
cells	NULL
such	NULL
as	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
basophils	NULL
,	NULL
and	NULL
eosino-phils	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
GM-CSF	NULL
may	NULL
be	NULL
one	NULL
of	NULL
the	NULL
mediators	NULL
of	NULL
acute	NULL
and	NULL
chronic	NULL
inflammatory	NULL
conditions	NULL
suck	NULL
as	NULL
rheumatoid	NULL
arthritis	NULL
,	NULL
asthma	NULL
,	NULL
and	NULL
psoriasis	NULL
.	NULL
``	NULL

GM-CSF	NULL
is	NULL
typically	NULL
induced	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
such	NULL
as	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
(	NULL
TNF-a	NULL
)	NULL
and	NULL
IL-1	NULL
and	NULL
its	NULL
expression	NULL
is	NULL
regulated	NULL
at	NULL
both	NULL
transcriptional	NULL
and	NULL
posttranscriptional	NULL
levels	NULL
.	NULL
``	NULL

''	NULL
Agents	NULL
that	NULL
activate	NULL
the	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
Ca**	NULL
pathways	NULL
in	NULL
endothelial	NULL
cells	NULL
would	NULL
also	NULL
be	NULL
expected	NULL
to	NULL
induce	NULL
GM-CSF	NULL
expression	NULL
.	NULL

In	NULL
addition	NULL
to	NULL
producing	NULL
cytokines	NULL
,	NULL
activated	NULL
endothelial	NULL
cells	NULL
also	NULL
express	NULL
the	NULL
cell	NULL
surface	NULL
adhesion	NULL
molecules	NULL
E-selectin	NULL
,	NULL
P-selectin	NULL
,	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-l	NULL
(	NULL
VCAM-1	NULL
)	NULL
,	NULL
and	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
(	NULL
ICAM-1	NULL
)	NULL
,	NULL
which	NULL
mediate	NULL
recruitment	NULL
and	NULL
transmigration	NULL
of	NULL
leukocytes	NULL
across	NULL
the	NULL
endothelium	NULL
.	NULL

*	NULL
``	NULL
*	NULL
``	NULL
°	NULL
E-selectin	NULL
(	NULL
previously	NULL
termed	NULL
ELAM-1	NULL
)	NULL
is	NULL
a	NULL
cell	NULL
surface	NULL
glycoprotein	NULL
found	NULL
exclu-	NULL
From	NULL
the	NULL
Division	NULL
of	NULL
Human	NULL
Immunology	NULL
,	NULL
Hanson	NULL
Centre	NULL
For	NULL
Cancer	NULL
Research	NULL
,	NULL
Institute	NULL
for	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
Ade-laide	NULL
,	NULL
Australia	NULL
.	NULL

Submitted	NULL
December	NULL
27	NULL
,	NULL
1994	NULL
;	NULL
accepted	NULL
June	NULL
2	NULL
,	NULL
1995	NULL
.	NULL

Supported	NULL
by	NULL
the	NULL
National	NULL
Health	NULL
and	NULL
Medical	NULL
Research	NULL
Council	NULL
of	NULL
Australia	NULL
and	NULL
the	NULL
Anti-Cancer	NULL
Foundation	NULL
of	NULL
the	NULL
Universities	NULL
of	NULL
South	NULL
Australia	NULL
.	NULL

Address	NULL
reprint	NULL
requests	NULL
to	NULL
Peter	NULL
N.	NULL
Cockerill	NULL
,	NULL
Division	NULL
of	NULL
Human	NULL
Immunology	NULL
,	NULL
Hanson	NULL
Centre	NULL
for	NULL
Cancer	NULL
Research	NULL
,	NULL
Institute	NULL
for	NULL
Medical	NULL
and	NULL
Veterinary	NULL
Science	NULL
,	NULL
PO	NULL
Box	NULL
14	NULL
,	NULL
Rundle	NULL
Mall	NULL
,	NULL
Frome	NULL
Rd	NULL
,	NULL
Adelaide	NULL
5000	NULL
,	NULL
Australia	NULL
.	NULL

The	NULL
publication	NULL
costs	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
page	NULL
charge	NULL
payment	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
``	NULL
advertisement	NULL
``	NULL
'	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

©	NULL
1995	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
.	NULL

0006-4971/95/8607-0018	NULL
$	NULL
3.00/0	NULL
2689	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2690	NULL
sively	NULL
on	NULL
endothelial	NULL
cells	NULL
that	NULL
interacts	NULL
with	NULL
receptors	NULL
on	NULL
a	NULL
subset	NULL
of	NULL
leukocytes	NULL
that	NULL
include	NULL
neutrophils	NULL
,	NULL
eosinophils	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
a	NULL
subset	NULL
of	NULL
memory	NULL
T	NULL
cells	NULL
.	NULL
``	NULL

E-selectin	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
earliest	NULL
stages	NULL
of	NULL
leukocyte	NULL
recruitment	NULL
as	NULL
it	NULL
mediates	NULL
the	NULL
initial	NULL
tethering	NULL
and	NULL
rolling	NULL
of	NULL
leukocytes	NULL
across	NULL
the	NULL
endothelium	NULL
.	NULL
``	NULL

Acute	NULL
and	NULL
chronic	NULL
inflammatory	NULL
conditions	NULL
are	NULL
typically	NULL
maintained	NULL
by	NULL
the	NULL
activation	NULL
of	NULL
both	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
that	NULL
function	NULL
in	NULL
concert	NULL
to	NULL
orchestrate	NULL
the	NULL
interactions	NULL
between	NULL
numerous	NULL
participating	NULL
cell	NULL
types	NULL
.	NULL

Elevated	NULL
expression	NULL
of	NULL
E-selectin	NULL
,	NULL
for	NULL
example	NULL
,	NULL
is	NULL
associated	NULL
with	NULL
inflammatory	NULL
conditions	NULL
such	NULL
as	NULL
asthma	NULL
,	NULL
``	NULL
'	NULL
rheumatoid	NULL
arthri-tis	NULL
,	NULL
``	NULL
and	NULL
psoriasis	NULL
.	NULL
``	NULL

While	NULL
CsA	NULL
is	NULL
more	NULL
commonly	NULL
used	NULL
as	NULL
an	NULL
immunosuppressive	NULL
agent	NULL
to	NULL
prevent	NULL
organ	NULL
transplant	NULL
rejection	NULL
,	NULL
it	NULL
has	NULL
also	NULL
been	NULL
found	NULL
to	NULL
be	NULL
effective	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
a	NULL
variety	NULL
of	NULL
chronic	NULL
inflammatory	NULL
and	NULL
autoimmune	NULL
disorders	NULL
such	NULL
as	NULL
psoriasis	NULL
,	NULL
``	NULL
asthma	NULL
,	NULL
``	NULL
ulcerative	NULL
colitis	NULL
,	NULL
``	NULL
and	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL
``	NULL

While	NULL
some	NULL
of	NULL
the	NULL
benefits	NULL
of	NULL
these	NULL
treatments	NULL
can	NULL
be	NULL
attributed	NULL
to	NULL
actions	NULL
against	NULL
T	NULL
cells	NULL
,	NULL
there	NULL
may	NULL
be	NULL
additional	NULL
direct	NULL
effects	NULL
on	NULL
either	NULL
the	NULL
activation	NULL
or	NULL
trafficking	NULL
of	NULL
cell	NULL
types	NULL
such	NULL
as	NULL
neutrophils	NULL
,	NULL
eosinophils	NULL
,	NULL
and	NULL
monocytes	NULL
.	NULL

To	NULL
gain	NULL
a	NULL
better	NULL
understanding	NULL
of	NULL
the	NULL
involvement	NULL
of	NULL
the	NULL
endothelium	NULL
in	NULL
inflammation	NULL
,	NULL
we	NULL
have	NULL
investigated	NULL
the	NULL
regulation	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
E-selectin	NULL
genes	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
have	NULL
used	NULL
passaged	NULL
human	NULL
umbilical	NULL
vein	NULL
endothelial	NULL
cells	NULL
(	NULL
HUVEs	NULL
)	NULL
and	NULL
the	NULL
recently	NULL
derived	NULL
endothelial	NULL
cell	NULL
line	NULL
C11STH	NULL
.	NULL

**	NULL
We	NULL
initially	NULL
cloned	NULL
C11STH	NULL
cells	NULL
from	NULL
a	NULL
spontaneous	NULL
transformant	NULL
that	NULL
arose	NULL
in	NULL
a	NULL
culture	NULL
of	NULL
HUVEs	NULL
and	NULL
showed	NULL
that	NULL
they	NULL
have	NULL
a	NULL
repertoire	NULL
of	NULL
adhesion	NULL
molecules	NULL
and	NULL
TNF-a	NULL
receptors	NULL
similar	NULL
to	NULL
that	NULL
found	NULL
in	NULL
normal	NULL
HUVEs	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
we	NULL
found	NULL
that	NULL
,	NULL
as	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
was	NULL
required	NULL
for	NULL
efficient	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Interestingly	NULL
,	NULL
these	NULL
effects	NULL
appeared	NULL
to	NULL
be	NULL
mediated	NULL
in	NULL
part	NULL
by	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
.	NULL

Furthermore	NULL
,	NULL
NFAT	NULL
and	NULL
GM-CSF	NULL
induction	NULL
in	NULL
endothelial	NULL
cells	NULL
was	NULL
suppressed	NULL
by	NULL
CsA	NULL
.	NULL

The	NULL
induction	NULL
of	NULL
E-selectin	NULL
in	NULL
endothelial	NULL
cells	NULL
and	NULL
acquired	NULL
ability	NULL
to	NULL
support	NULL
neutrophil	NULL
adhesion	NULL
were	NULL
also	NULL
inhibited	NULL
by	NULL
CsA	NULL
,	NULL
suggesting	NULL
a	NULL
wider	NULL
role	NULL
for	NULL
this	NULL
drug	NULL
in	NULL
combating	NULL
inflammation	NULL
.	NULL

In	NULL
the	NULL
course	NULL
of	NULL
these	NULL
studies	NULL
we	NULL
established	NULL
that	NULL
the	NULL
endothelial	NULL
cell	NULL
line	NULL
C11STH	NULL
``	NULL
is	NULL
a	NULL
valuable	NULL
model	NULL
system	NULL
for	NULL
studying	NULL
inflammatory	NULL
events	NULL
in	NULL
the	NULL
endothelium	NULL
.	NULL

MATERIALS	NULL
AND	NULL
METHODS	NULL
Reagents	NULL
.	NULL

The	NULL
phorbol	NULL
ester	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
(	NULL
PMA	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
(	NULL
St	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
,	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
was	NULL
purchased	NULL
from	NULL
Boehringer	NULL
(	NULL
Mannheim	NULL
,	NULL
Germany	NULL
)	NULL
,	NULL
forskolin	NULL
was	NULL
purchased	NULL
from	NULL
Calbiochem	NULL
(	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
)	NULL
,	NULL
cyclosporin	NULL
A	NULL
(	NULL
CsA	NULL
)	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
Sandoz	NULL
(	NULL
Basel	NULL
,	NULL
Switzer-land	NULL
)	NULL
,	NULL
DNasel	NULL
was	NULL
purchased	NULL
from	NULL
Worthington	NULL
(	NULL
Freehold	NULL
,	NULL
NJ	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
and	NULL
interferon-y	NULL
(	NULL
IFN-y	NULL
)	NULL
were	NULL
provided	NULL
by	NULL
Genetech	NULL
(	NULL
San	NULL
Francisco	NULL
,	NULL
CA	NULL
)	NULL
.	NULL

PMA	NULL
was	NULL
prepared	NULL
as	NULL
a	NULL
1-mg/mL	NULL
stock	NULL
in	NULL
dimethyl	NULL
sulfoxide	NULL
(	NULL
DMSO	NULL
)	NULL
,	NULL
A23187	NULL
as	NULL
a	NULL
20-mmol/L	NULL
stock	NULL
in	NULL
DMSO	NULL
,	NULL
forskolin	NULL
as	NULL
a	NULL
10-mmo	NULL
{	NULL
/L	NULL
stock	NULL
in	NULL
DMSO	NULL
,	NULL
and	NULL
CsA	NULL
as	NULL
a	NULL
I-mmo/L	NULL
stock	NULL
in	NULL
ethanol	NULL
.	NULL

Oligonucleotides	NULL
.	NULL

-	NULL
Oligonucleotide	NULL
duplexes	NULL
used	NULL
as	NULL
probes	NULL
and	NULL
competitors	NULL
had	NULL
the	NULL
following	NULL
sequences	NULL
,	NULL
with	NULL
complementary	NULL
single	NULL
stranded	NULL
regions	NULL
at	NULL
each	NULL
end	NULL
shown	NULL
in	NULL
lower	NULL
case	NULL
for	NULL
the	NULL
COCKERILL	NULL
ET	NULL
AL	NULL
upper	NULL
strand	NULL
only	NULL
:	NULL
GM430	NULL
,	NULL
gatcTCACACATCTTTCTCATGGAA-AGATGA	NULL
;	NULL
IL-2	NULL
NFAT	NULL
,	NULL
gatcCGAAAGGAGGAAAAACTGTTT-CATACAGAAG	NULL
;	NULL
X	NULL
,	NULL
TCGCCAATGAGCTCCCGGGTCGACTGC-AGAAGCTTC	NULL
;	NULL
Igk	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
AACAGAGGGGACTTTCCGAGG-CCATCT	NULL
;	NULL
E-selectin	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
aatCGTTTTTGGATGCCATTG-GGGATTTCCTCTTTACTGGATGTG	NULL
.	NULL

The	NULL
GM430	NULL
sequence	NULL
is	NULL
a	NULL
high	NULL
affinity	NULL
NFATp/c	NULL
binding	NULL
site	NULL
located	NULL
in	NULL
the	NULL
GM-CSF	NULL
en-hancer	NULL
.	NULL

*	NULL
``	NULL
Plasmids	NULL
.	NULL

-	NULL
The	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmid	NULL
pGMIuc®	NULL
had	NULL
a	NULL
655-bp	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
-627	NULL
to	NULL
+28	NULL
)	NULL
upstream	NULL
of	NULL
the	NULL
luciferase	NULL
gene	NULL
.	NULL

The	NULL
plasmid	NULL
pGMEluc	NULL
has	NULL
a	NULL
716-bp	NULL
Bgill	NULL
fragment	NULL
of	NULL
the	NULL
human	NULL
GM-CSF	NULL
enhancer	NULL
placed	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
the	NULL
Bg/lI	NULL
site	NULL
of	NULL
pGMIluc	NULL
.	NULL

Cell	NULL
culture	NULL
.	NULL

C1ISTH	NULL
cells	NULL
and	NULL
HUVEs	NULL
were	NULL
cultured	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Antibodies	NULL
.	NULL

The	NULL
antibody	NULL
R59	NULL
was	NULL
raised	NULL
against	NULL
recombinant	NULL
truncated	NULL
NFATp	NULL
prepared	NULL
from	NULL
pNFATpXS	NULL
.	NULL
``	NULL

The	NULL
antibody	NULL
67.5	NULL
was	NULL
raised	NULL
against	NULL
peptide	NULL
72	NULL
of	NULL
purified	NULL
mouse	NULL
NFATp	NULL
.	NULL
``	NULL

These	NULL
antibodies	NULL
were	NULL
a	NULL
gift	NULL
from	NULL
A.	NULL
Rao	NULL
``	NULL
and	NULL
cross-react	NULL
between	NULL
human	NULL
and	NULL
mouse	NULL
NFATp	NULL
.	NULL

The	NULL
oct-1	NULL
antibody	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
R.	NULL
Sturm	NULL
(	NULL
Centre	NULL
for	NULL
Molecular	NULL
Biology	NULL
and	NULL
Biotechnology	NULL
,	NULL
Brisbane	NULL
,	NULL
Austra-lia	NULL
)	NULL
.	NULL

Gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
.	NULL

Gel	NULL
shift	NULL
assays	NULL
of	NULL
nuclear	NULL
extracts	NULL
were	NULL
essentially	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
and	NULL
used	NULL
0.2	NULL
ng	NULL
of	NULL
P-labeled	NULL
probe	NULL
,	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
protein	NULL
,	NULL
and	NULL
2	NULL
ug	NULL
of	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
in	NULL
a	NULL
15-uL	NULL
vol	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
previously	NULL
described	NULL
``	NULL
from	NULL
unstimulated	NULL
cells	NULL
and	NULL
cells	NULL
stimulated	NULL
for	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
pmol/L	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
0.1	NULL
umol/L	NULL
CsA	NULL
.	NULL

CsA	NULL
was	NULL
added	NULL
10	NULL
minutes	NULL
before	NULL
the	NULL
addition	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
.	NULL

Assays	NULL
of	NULL
recombinant	NULL
proteins	NULL
differed	NULL
in	NULL
that	NULL
they	NULL
used	NULL
200	NULL
ng	NULL
poly	NULL
(	NULL
dI-dC	NULL
)	NULL
,	NULL
4	NULL
mmol/L	NULL
dithiothreitol	NULL
and	NULL
0.3	NULL
mg/mL	NULL
bovine	NULL
serum	NULL
albumin	NULL
together	NULL
with	NULL
0.5	NULL
ng	NULL
NFATp	NULL
,	NULL
10	NULL
ng	NULL
NF-kB	NULL
p50	NULL
,	NULL
or	NULL
0.07	NULL
uL	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

The	NULL
NFATp	NULL
was	NULL
a	NULL
293-amino	NULL
acid	NULL
truncated	NULL
derivative	NULL
of	NULL
NFATp	NULL
containing	NULL
the	NULL
DNA-binding	NULL
domain	NULL
and	NULL
was	NULL
prepared	NULL
from	NULL
the	NULL
plasmid	NULL
pQE-31	NULL
#	NULL
1	NULL
(	NULL
a	NULL
gift	NULL
from	NULL
A.	NULL
Rao	NULL
)	NULL
,	NULL
which	NULL
is	NULL
derived	NULL
from	NULL
pNFATpXS	NULL
,	NULL
``	NULL
by	NULL
expression	NULL
in	NULL
Escherichia	NULL
coli	NULL
and	NULL
chromatography	NULL
on	NULL
Quiagen	NULL
Ni	NULL
'	NULL
:	NULL
*	NULL
NTA	NULL
agarose	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
.	NULL

NF-kB	NULL
p50	NULL
was	NULL
purchased	NULL
from	NULL
Promega	NULL
(	NULL
Madison	NULL
,	NULL
WI	NULL
)	NULL
,	NULL
while	NULL
the	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
used	NULL
here	NULL
was	NULL
a	NULL
gift	NULL
of	NULL
purified	NULL
recombinant	NULL
truncated	NULL
protein	NULL
(	NULL
amino	NULL
acids	NULL
1-313	NULL
)	NULL
supplied	NULL
by	NULL
S.	NULL
Gerondakis	NULL
(	NULL
Walter	NULL
and	NULL
Eliza	NULL
Hall	NULL
Institute	NULL
,	NULL
Melbourne	NULL
,	NULL
Australia	NULL
)	NULL
.	NULL

``	NULL
*	NULL
GM-CSF	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
.	NULL

_	NULL
GM-CSF	NULL
protein	NULL
concentrations	NULL
in	NULL
cell	NULL
culture	NULL
supernatants	NULL
were	NULL
determined	NULL
according	NULL
to	NULL
manufacturer	NULL
's	NULL
instructions	NULL
using	NULL
a	NULL
human	NULL
GM-CSF	NULL
enzyme-linked	NULL
immunosorbent	NULL
assay	NULL
(	NULL
ELISA	NULL
)	NULL
kit	NULL
supplied	NULL
by	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
(	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Supernatants	NULL
were	NULL
harvested	NULL
from	NULL
cultures	NULL
containing	NULL
2	NULL
X	NULL
10°	NULL
cells	NULL
seeded	NULL
in	NULL
24-well	NULL
trays	NULL
with	NULL
400	NULL
ul	NULL
.	NULL

medium	NULL
.	NULL

Cultures	NULL
were	NULL
initially	NULL
incubated	NULL
for	NULL
24	NULL
hours	NULL
and	NULL
then	NULL
activated	NULL
for	NULL
16	NULL
hours	NULL
as	NULL
indicated	NULL
.	NULL

GM-CSF	NULL
mRNA	NULL
assays	NULL
.	NULL

-	NULL
GM-CSF	NULL
mRNA	NULL
levels	NULL
were	NULL
assayed	NULL
as	NULL
previously	NULL
described®	NULL
after	NULL
stimulation	NULL
of	NULL
cells	NULL
for	NULL
8	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
pmol/L	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
0.1	NULL
pmol/L	NULL
CsA	NULL
.	NULL

Briefly	NULL
,	NULL
RNA	NULL
was	NULL
prepared	NULL
by	NULL
the	NULL
guanidine	NULL
lysis	NULL
method	NULL
and	NULL
assayed	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
.	NULL

Each	NULL
hybridization	NULL
reaction	NULL
contained	NULL
probes	NULL
for	NULL
both	NULL
the	NULL
GM-CSF	NULL
and	NULL
the	NULL
constitutively	NULL
expressed	NULL
glyceraldehyde-3-phosphate	NULL
dehydroge-nase	NULL
(	NULL
GAPDH	NULL
)	NULL
genes	NULL
,	NULL
and	NULL
the	NULL
levels	NULL
of	NULL
GM-CSF	NULL
expression	NULL
were	NULL
expressed	NULL
relative	NULL
to	NULL
GAPDH	NULL
.	NULL

DNase	NULL
I	NULL
hypersensitive	NULL
site	NULL
analysis	NULL
.	NULL

-	NULL
DNase	NULL
I	NULL
hypersensitive	NULL
sites	NULL
(	NULL
DH	NULL
)	NULL
sites	NULL
in	NULL
C11STH	NULL
cells	NULL
,	NULL
HUVEs	NULL
,	NULL
Jurkat	NULL
cells	NULL
,	NULL
and	NULL
peripheral	NULL
blood	NULL
T	NULL
lymphocytes	NULL
were	NULL
assayed	NULL
as	NULL
described®	NULL
after	NULL
stimulating	NULL
the	NULL
cells	NULL
for	NULL
4	NULL
to	NULL
6	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
pmol/L	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
or	NULL
100	NULL
U/mL	NULL
.	NULL

TNF-a	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
0.1	NULL
pmol/L	NULL
CsA	NULL
.	NULL

Filters	NULL
were	NULL
first	NULL
hybridized	NULL
with	NULL
the	NULL
GM-CSF	NULL
probe	NULL
,	NULL
``	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
AND	NULL
E-SELECTIN	NULL
GENE	NULL
EXPRESSION	NULL
then	NULL
stripped	NULL
by	NULL
washing	NULL
in	NULL
50	NULL
%	NULL
formamide	NULL
at	NULL
65°C	NULL
,	NULL
before	NULL
rehy-bridizing	NULL
with	NULL
the	NULL
E-selectin	NULL
probe	NULL
.	NULL

The	NULL
E-selectin	NULL
probe	NULL
was	NULL
a	NULL
1.7-kb	NULL
Bgill/EcoRI	NULL
fragment	NULL
normally	NULL
located	NULL
1.3	NULL
to	NULL
3	NULL
kb	NULL
downstream	NULL
of	NULL
the	NULL
human	NULL
E-selectin	NULL
gene	NULL
transcription	NULL
start	NULL
site	NULL
,	NULL
and	NULL
was	NULL
a	NULL
gift	NULL
from	NULL
T.	NULL
Collins	NULL
(	NULL
Brigham	NULL
and	NULL
Women	NULL
's	NULL
Hospital	NULL
,	NULL
Boston	NULL
,	NULL
MA	NULL
)	NULL
.	NULL

T	NULL
lymphocytes	NULL
were	NULL
freshly	NULL
purified	NULL
from	NULL
peripheral	NULL
blood	NULL
by	NULL
Ficoll	NULL
centrifugation	NULL
to	NULL
isolate	NULL
mononuclear	NULL
cells	NULL
,	NULL
elutriation	NULL
to	NULL
remove	NULL
monocytes	NULL
,	NULL
and	NULL
nylon	NULL
wool	NULL
chromatography	NULL
to	NULL
remove	NULL
B	NULL
cells	NULL
.	NULL

Transfection	NULL
assays	NULL
.	NULL

-	NULL
Luciferase	NULL
reporter	NULL
gene	NULL
activities	NULL
were	NULL
determined	NULL
as	NULL
previously	NULL
described	NULL
by	NULL
transfecting	NULL
20	NULL
ug	NULL
of	NULL
each	NULL
plasmid	NULL
construct	NULL
into	NULL
1	NULL
x	NULL
10°	NULL
C11STH	NULL
cells	NULL
by	NULL
the	NULL
diethylaminoethy	NULL
]	NULL
(	NULL
DEAE	NULL
)	NULL
dextran	NULL
procedure	NULL
``	NULL
and	NULL
measuring	NULL
luciferase	NULL
expression	NULL
``	NULL
``	NULL
after	NULL
stimulation	NULL
with	NULL
2	NULL
pmol/L	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
and	NULL
20	NULL
ng/mL	NULL
PMA	NULL
for	NULL
9	NULL
hours	NULL
in	NULL
the	NULL
presence	NULL
and	NULL
absence	NULL
of	NULL
0.1	NULL
gmol/L	NULL
CsA	NULL
.	NULL

Neutrophil	NULL
adhesion	NULL
assays	NULL
.	NULL

-	NULL
Neutrophil	NULL
adhesion	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

Briefly	NULL
,	NULL
confluent	NULL
monolayers	NULL
of	NULL
C11STH	NULL
cells	NULL
were	NULL
incubated	NULL
with	NULL
100	NULL
U/mL	NULL
TNF-	NULL
«	NULL
in	NULL
the	NULL
presence	NULL
or	NULL
absence	NULL
of	NULL
1	NULL
pmol/L	NULL
CsA	NULL
.	NULL

After	NULL
4	NULL
hours	NULL
'	NULL
activation	NULL
,	NULL
``	NULL
Cr-labeled	NULL
neutrophils	NULL
(	NULL
9	NULL
x	NULL
10°	NULL
cpm	NULL
)	NULL
were	NULL
added	NULL
and	NULL
incubated	NULL
at	NULL
room	NULL
temperature	NULL
(	NULL
approximately	NULL
22°C	NULL
)	NULL
for	NULL
15	NULL
minutes	NULL
.	NULL

After	NULL
several	NULL
washes	NULL
with	NULL
medium	NULL
,	NULL
neutrophil	NULL
adherence	NULL
was	NULL
estimated	NULL
by	NULL
measuring	NULL
bound	NULL
``	NULL
Cr	NULL
.	NULL

E-selectin	NULL
and	NULL
VCAM-1	NULL
expression	NULL
.	NULL

-	NULL
Cell	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
and	NULL
VCAM-1	NULL
on	NULL
C11STH	NULL
cells	NULL
was	NULL
determined	NULL
by	NULL
flow	NULL
cytometric	NULL
(	NULL
FACS	NULL
)	NULL
analysis	NULL
using	NULL
specific	NULL
antibodies	NULL
for	NULL
E-selectin	NULL
and	NULL
VCAM-1	NULL
,	NULL
as	NULL
previously	NULL
described	NULL
.	NULL
``	NULL

''	NULL
Before	NULL
analysis	NULL
,	NULL
cells	NULL
were	NULL
stimulated	NULL
for	NULL
4	NULL
hours	NULL
with	NULL
different	NULL
combinations	NULL
100	NULL
U/mL	NULL
IFN-y	NULL
,	NULL
100	NULL
U/mL	NULL
TNF-a	NULL
,	NULL
20	NULL
ng/mL	NULL
PMA	NULL
,	NULL
2	NULL
umol/L	NULL
A23187	NULL
(	NULL
I	NULL
)	NULL
,	NULL
and	NULL
10	NULL
pmol/L	NULL
forskolin	NULL
.	NULL

RESULTS	NULL
Activated	NULL
endothelial	NULL
cells	NULL
express	NULL
NFAT	NULL
.	NULL

CsA	NULL
is	NULL
a	NULL
potent	NULL
immunosuppressive	NULL
drug	NULL
known	NULL
to	NULL
function	NULL
in	NULL
T	NULL
cells	NULL
by	NULL
inhibiting	NULL
induction	NULL
of	NULL
the	NULL
transcription	NULL
factor	NULL
NFAT	NULL
.	NULL

Although	NULL
there	NULL
have	NULL
been	NULL
no	NULL
previous	NULL
reports	NULL
of	NULL
NFAT	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
CsA	NULL
is	NULL
used	NULL
as	NULL
an	NULL
antiinflammatory	NULL
agent	NULL
,	NULL
and	NULL
some	NULL
of	NULL
its	NULL
actions	NULL
could	NULL
be	NULL
mediated	NULL
by	NULL
suppression	NULL
of	NULL
factors	NULL
in	NULL
the	NULL
endothelium	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
examined	NULL
whether	NULL
NFAT	NULL
can	NULL
be	NULL
induced	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
pathways	NULL
known	NULL
to	NULL
activate	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

To	NULL
this	NULL
end	NULL
,	NULL
we	NULL
stimulated	NULL
C11STH	NULL
cells	NULL
and	NULL
passaged	NULL
HUVEs	NULL
with	NULL
a	NULL
combination	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
.	NULL

These	NULL
signals	NULL
mimic	NULL
the	NULL
phospholipase	NULL
C	NULL
driven	NULL
activation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
and	NULL
increase	NULL
in	NULL
cytosolic	NULL
Ca**	NULL
and	NULL
induce	NULL
the	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
components	NULL
of	NULL
NFAT	NULL
,	NULL
respectively	NULL
.	NULL

We	NULL
performed	NULL
gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
nuclear	NULL
extracts	NULL
prepared	NULL
from	NULL
activated	NULL
HUVEs	NULL
and	NULL
C11STH	NULL
cells	NULL
using	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
GM43O0	NULL
sequence	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
NFATp/c	NULL
binding	NULL
(	NULL
lefthand	NULL
panel	NULL
in	NULL
Fig	NULL
1	NULL
)	NULL
and	NULL
the	NULL
human	NULL
IL-2	NULL
gene	NULL
distal	NULL
NFAT	NULL
site	NULL
as	NULL
a	NULL
probe	NULL
for	NULL
NFAT	NULL
(	NULL
righthand	NULL
panel	NULL
in	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

The	NULL
IL-2	NULL
site	NULL
served	NULL
as	NULL
the	NULL
prototypic	NULL
NFAT	NULL
site	NULL
most	NULL
commonly	NULL
used	NULL
to	NULL
assay	NULL
for	NULL
the	NULL
presence	NULL
of	NULL
NFAT	NULL
in	NULL
T	NULL
cells	NULL
as	NULL
it	NULL
cooperatively	NULL
binds	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
to	NULL
form	NULL
NFAT	NULL
complexes	NULL
.	NULL
``	NULL

The	NULL
GM430	NULL
site	NULL
is	NULL
a	NULL
high-affinity	NULL
NFATp	NULL
site	NULL
that	NULL
is	NULL
able	NULL
to	NULL
associate	NULL
strongly	NULL
with	NULL
the	NULL
NFATp/c	NULL
component	NULL
of	NULL
NFAT	NULL
independently	NULL
of	NULL
AP-1	NULL
.	NULL

Significantly	NULL
,	NULL
nuclear	NULL
extracts	NULL
from	NULL
HUVEs	NULL
and	NULL
C11STH	NULL
cells	NULL
both	NULL
formed	NULL
inducible	NULL
NFATp/c-like	NULL
complexes	NULL
with	NULL
the	NULL
GM430	NULL
element	NULL
and	NULL
NFAT-like	NULL
complexes	NULL
with	NULL
the	NULL
IL-	NULL
2691	NULL
2	NULL
NFAT	NULL
site	NULL
that	NULL
comigrated	NULL
with	NULL
Jurkat	NULL
T-cell	NULL
complexes	NULL
in	NULL
gel	NULL
mobility	NULL
shift	NULL
assays	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

As	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
CsA	NULL
completely	NULL
inhibited	NULL
the	NULL
induction	NULL
of	NULL
these	NULL
endothelial	NULL
cell	NULL
NFAT	NULL
and	NULL
NFATp/c-like	NULL
complexes	NULL
(	NULL
Fig	NULL
1	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
complex	NULL
formation	NULL
with	NULL
both	NULL
probes	NULL
was	NULL
completely	NULL
inhibited	NULL
when	NULL
either	NULL
the	NULL
IL-2	NULL
or	NULL
GM430	NULL
NFAT	NULL
elements	NULL
were	NULL
included	NULL
as	NULL
DNA	NULL
competitors	NULL
,	NULL
but	NULL
only	NULL
partially	NULL
inhibited	NULL
when	NULL
an	NULL
unrelated	NULL
competitor	NULL
(	NULL
X	NULL
)	NULL
was	NULL
used	NULL
.	NULL

NFATp	NULL
appeared	NULL
to	NULL
be	NULL
the	NULL
major	NULL
protein	NULL
contributing	NULL
to	NULL
NFATp/c-like	NULL
complexes	NULL
with	NULL
the	NULL
GM430	NULL
probe	NULL
in	NULL
C11STH	NULL
and	NULL
HUVE	NULL
extracts	NULL
as	NULL
antibodies	NULL
raised	NULL
against	NULL
either	NULL
recombinant	NULL
NFAT	NULL
p	NULL
or	NULL
to	NULL
an	NULL
NFAT	NULL
p	NULL
peptide	NULL
specifically	NULL
inhibited	NULL
formation	NULL
of	NULL
or	NULL
super-shifted	NULL
NFATp-like	NULL
complexes	NULL
as	NULL
efficiently	NULL
as	NULL
they	NULL
did	NULL
with	NULL
Jurkat	NULL
cell	NULL
extracts	NULL
(	NULL
Fig	NULL
2	NULL
)	NULL
.	NULL

Addition	NULL
of	NULL
a	NULL
5-	NULL
to	NULL
20-fold	NULL
greater	NULL
amount	NULL
of	NULL
oct-1	NULL
antiserum	NULL
had	NULL
little	NULL
effect	NULL
on	NULL
NFATp	NULL
complex	NULL
formation	NULL
with	NULL
the	NULL
endothelial	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

As	NULL
the	NULL
67.1	NULL
NFATp	NULL
antibody	NULL
was	NULL
raised	NULL
against	NULL
a	NULL
peptide	NULL
not	NULL
conserved	NULL
in	NULL
NFATc	NULL
,	NULL
there	NULL
appeared	NULL
to	NULL
be	NULL
little	NULL
or	NULL
no	NULL
NFAT	NULL
'	NULL
c	NULL
present	NULL
in	NULL
either	NULL
the	NULL
endothelial	NULL
cell	NULL
or	NULL
the	NULL
Jurkat	NULL
cell	NULL
extracts	NULL
employed	NULL
in	NULL
this	NULL
study	NULL
.	NULL

NFATp	NULL
induction	NULL
in	NULL
endothelial	NULL
cells	NULL
may	NULL
require	NULL
a	NULL
Ca**	NULL
signal	NULL
not	NULL
provided	NULL
by	NULL
proinflammatory	NULL
cytokines	NULL
,	NULL
as	NULL
TNF-a	NULL
did	NULL
not	NULL
induce	NULL
NFAT	NULL
p	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
TNF-a	NULL
was	NULL
a	NULL
more	NULL
efficient	NULL
inducer	NULL
of	NULL
NF-KB	NULL
in	NULL
endothelial	NULL
cells	NULL
than	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

GM-CSF	NULL
expression	NULL
is	NULL
regulated	NULL
by	NULL
CsA	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

If	NULL
NFATp	NULL
regulates	NULL
gene	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
then	NULL
GM-CSF	NULL
gene	NULL
activation	NULL
via	NULL
Ca*	NULL
``	NULL
*	NULL
pathways	NULL
in	NULL
endothelial	NULL
cells	NULL
should	NULL
also	NULL
be	NULL
CsA-sensitive	NULL
.	NULL

To	NULL
explore	NULL
this	NULL
possibility	NULL
,	NULL
we	NULL
examined	NULL
GM-CSF	NULL
synthesis	NULL
in	NULL
four	NULL
independent	NULL
lines	NULL
of	NULL
passaged	NULL
HUVEs	NULL
.	NULL

As	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
level	NULL
of	NULL
GM-CSF	NULL
secretion	NULL
by	NULL
HUVEs	NULL
was	NULL
increased	NULL
100-fold	NULL
by	NULL
the	NULL
combined	NULL
actions	NULL
of	NULL
the	NULL
phorbol	NULL
ester	NULL
PMA	NULL
and	NULL
the	NULL
calcium	NULL
ionophore	NULL
A23187	NULL
(	NULL
PMA/I	NULL
,	NULL
Fig	NULL
3	NULL
)	NULL
.	NULL

For	NULL
each	NULL
of	NULL
the	NULL
four	NULL
lines	NULL
of	NULL
activated	NULL
HUVEs	NULL
,	NULL
there	NULL
was	NULL
a	NULL
decrease	NULL
in	NULL
GM-CSF	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
pmol/L	NULL
CsA	NULL
,	NULL
with	NULL
an	NULL
average	NULL
reduction	NULL
of	NULL
50	NULL
%	NULL
.	NULL

As	NULL
we	NULL
anticipated	NULL
that	NULL
CsA	NULL
would	NULL
inhibit	NULL
GM-CSF	NULL
at	NULL
the	NULL
transcriptional	NULL
level	NULL
,	NULL
we	NULL
also	NULL
performed	NULL
RNase	NULL
protection	NULL
assays	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
in	NULL
HUVEs	NULL
and	NULL
C11STH	NULL
cells	NULL
.	NULL

Just	NULL
as	NULL
we	NULL
observed	NULL
for	NULL
GM-CSF	NULL
protein	NULL
synthesis	NULL
,	NULL
GM-CSF	NULL
mRNA	NULL
was	NULL
strongly	NULL
induced	NULL
in	NULL
both	NULL
HUVEs	NULL
and	NULL
C11STH	NULL
cells	NULL
by	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

GM-CSF	NULL
mRNA	NULL
induction	NULL
required	NULL
calcium	NULL
ionophore	NULL
as	NULL
well	NULL
PMA	NULL
,	NULL
as	NULL
sixfold	NULL
less	NULL
GM-CSF	NULL
mRNA	NULL
was	NULL
detected	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
alone	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
gmoV/L	NULL
CsA	NULL
the	NULL
induction	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
was	NULL
reduced	NULL
by	NULL
65	NULL
%	NULL
in	NULL
HUVEs	NULL
and	NULL
56	NULL
%	NULL
in	NULL
C11STH	NULL
cells	NULL
(	NULL
Fig	NULL
4	NULL
)	NULL
.	NULL

This	NULL
inhibition	NULL
appeared	NULL
to	NULL
be	NULL
specific	NULL
,	NULL
as	NULL
we	NULL
observed	NULL
no	NULL
effect	NULL
of	NULL
CsA	NULL
on	NULL
IL-8	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CsA	NULL
also	NULL
appeared	NULL
to	NULL
have	NULL
little	NULL
effect	NULL
on	NULL
induction	NULL
of	NULL
GM-CSF	NULL
expression	NULL
by	NULL
pathways	NULL
that	NULL
do	NULL
not	NULL
use	NULL
Ca**	NULL
.	NULL

Hence	NULL
,	NULL
CsA	NULL
had	NULL
no	NULL
significant	NULL
influence	NULL
on	NULL
induction	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
or	NULL
protein	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
activated	NULL
with	NULL
TNF-a	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
GM-CSF	NULL
enhancer	NULL
exists	NULL
as	NULL
a	NULL
DNasel	NULL
hypersensitive	NULL
site	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

-	NULL
In	NULL
T	NULL
cells	NULL
,	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
exists	NULL
as	NULL
an	NULL
inducible	NULL
CsA-sensitive	NULL
DNaselI	NULL
hypersensitive	NULL
(	NULL
DH	NULL
)	NULL
site	NULL
that	NULL
spans	NULL
at	NULL
least	NULL
two	NULL
NFAT	NULL
sites	NULL
.	NULL
``	NULL

''	NULL
To	NULL
identify	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2692	NULL
COCKERILL	NULL
ET	NULL
AL	NULL
GM430	NULL
NFATp	NULL
probe	NULL
__	NULL
IL-2	NULL
NFAT	NULL
probe	NULL
:	NULL
[	NULL
HUVE	NULL
C-11	NULL
STH	NULL
\_	NULL
HUVE	NULL
C-11	NULL
STH	NULL
§	NULL
m-	NULL
Te	NULL
z	NULL
-g	NULL
]	NULL
€	NULL
<	NULL
oa	NULL
a	NULL
jut	NULL
8	NULL
5	NULL
]	NULL
<	NULL
9.2	NULL
$	NULL
&	NULL
$	NULL
$	NULL
q	NULL
B	NULL
-	NULL
J	NULL
ye	NULL
8	NULL
E	NULL
$	NULL
5	NULL
-	NULL
0	NULL
f	NULL
m	NULL
E	NULL
ZE	NULL
~	NULL
2	NULL
Sk	NULL
me	NULL
mi	NULL
a	NULL
35	NULL
ao	NULL
4	NULL
_o	NULL
s	NULL
OZ	NULL
8	NULL
y	NULL
-	NULL
mx	NULL
~	NULL
o	NULL
s	NULL
2	NULL
C4	NULL
mos	NULL
s	NULL
<	NULL
g	NULL
_	NULL
+0	NULL
+	NULL
+	NULL
é	NULL
A	NULL
_	NULL
E	NULL
E	NULL
_	NULL
+	NULL
_+	NULL
+	NULL
g	NULL
g	NULL
Fig	NULL
1	NULL
.	NULL

Gel	NULL
electrophetic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
3	NULL
£	NULL
£	NULL
ET	NULL
-	NULL
PMA7Z	NULL
&	NULL
A	NULL
#	NULL
1	NULL
2	NULL
A	NULL
A	NULL
@	NULL
PMA	NULL
/	NULL
I	NULL
A.	NULL
m	NULL
NFATp	NULL
and	NULL
NFAT	NULL
in	NULL
endothelial	NULL
cell	NULL
nuclear	NULL
extracts	NULL
.	NULL

NFAT	NULL
Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
from	NULL
passaged	NULL
>	NULL
bs	NULL
N	NULL
HUVEs	NULL
,	NULL
C11STH	NULL
cells	NULL
,	NULL
and	NULL
Jurkat	NULL
cells	NULL
that	NULL
were	NULL
ei-¢	NULL
a	NULL
I	NULL
!	NULL
'	NULL

<	NULL
-	NULL
.	NULL
'	NULL

Sil	NULL
ther	NULL
unstimulated	NULL
(	NULL
nil	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
2	NULL
to	NULL
3	NULL
hours	NULL
I*	NULL
-*	NULL
NFATp	NULL
|	NULL
pase	NULL
``	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
mmol/L	NULL
A23187	NULL
in	NULL
the	NULL
hand	NULL
bo	NULL
tba	NULL
mit	NULL
a	NULL
role	NULL
for	NULL
this	NULL
enhancer	NULL
in	NULL
the	NULL
GM-CSF	NULL
locus	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
DH	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
.	NULL

These	NULL
analyses	NULL
were	NULL
performed	NULL
both	NULL
in	NULL
C11STH	NULL
cells	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
and	NULL
in	NULL
passaged	NULL
HUVEs	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

We	NULL
located	NULL
two	NULL
DH	NULL
sites	NULL
that	NULL
coincided	NULL
with	NULL
the	NULL
proximal	NULL
promoter	NULL
and	NULL
the	NULL
previously	NULL
defined	NULL
enhancer	NULL
3	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
gene	NULL
.	NULL

The	NULL
DH	NULL
site	NULL
located	NULL
within	NULL
the	NULL
promoter	NULL
ap-	NULL
Jurkat	NULL
T	NULL
cells	NULL
C-11	NULL
STH	NULL
HUVE	NULL
|	NULL
g	NULL
IT	NULL
8	NULL
1	NULL
6	NULL
~	NULL
1	NULL
5	NULL
&	NULL
&	NULL
§	NULL
R	NULL
&	NULL
5	NULL
&	NULL
&	NULL
Eo	NULL
&	NULL
_	NULL
EoE	NULL
&	NULL
|	NULL
P	NULL
&	NULL
&	NULL
_	NULL
_o	NULL
$	NULL
A	NULL
R	NULL
&	NULL
$	NULL
2	NULL
2	NULL
g	NULL
$	NULL
&	NULL
T2	NULL
i	NULL
3	NULL
RoR	NULL
5	NULL
8	NULL
1	NULL
£	NULL
2	NULL
s	NULL
§	NULL
f	NULL
R	NULL
2	NULL
t	NULL
§	NULL
#	NULL
NFA	NULL
'	NULL
I	NULL
‘	NULL
;	NULL
N.	NULL
``	NULL
lull	NULL
ima	NULL
Fig	NULL
2	NULL
.	NULL

-	NULL
Gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
nuclear	NULL
extracts	NULL
binding	NULL
to	NULL
the	NULL
GM430	NULL
NFATp	NULL
probe	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
NFATp	NULL
antibodies	NULL
.	NULL

Assays	NULL
used	NULL
1	NULL
ug	NULL
stimulated	NULL
Jurkat	NULL
cell	NULL
nuclear	NULL
extract	NULL
or	NULL
5	NULL
ug	NULL
stimulated	NULL
C11STH	NULL
or	NULL
HUVE	NULL
nuclear	NULL
extract	NULL
.	NULL

Extracts	NULL
were	NULL
assayed	NULL
either	NULL
with	NULL
no	NULL
added	NULL
anti-sera	NULL
(	NULL
nil	NULL
)	NULL
or	NULL
after	NULL
preincubation	NULL
for	NULL
20	NULL
minutes	NULL
on	NULL
ice	NULL
with	NULL
0.2	NULL
uL	NULL
of	NULL
preimmune	NULL
serum	NULL
,	NULL
0.2	NULL
uL	NULL
R59	NULL
antisera	NULL
raised	NULL
against	NULL
recombinant	NULL
NFATp	NULL
,	NULL
0.05	NULL
pL	NULL
67.1	NULL
antisera	NULL
raised	NULL
against	NULL
an	NULL
NFATp	NULL
peptide	NULL
,	NULL
or	NULL
1	NULL
wL	NULL
of	NULL
an	NULL
antisera	NULL
raised	NULL
against	NULL
oct-1	NULL
.	NULL

The	NULL
67.1-antisera	NULL
produced	NULL
super-shifted	NULL
complexes	NULL
characteristic	NULL
of	NULL
specific	NULL
NFATp	NULL
binding	NULL
and	NULL
does	NULL
not	NULL
cross-react	NULL
with	NULL
NFATc	NULL
.	NULL

b	NULL
ete	NULL
a	NULL
W	NULL
e	NULL
but	NULL
s	NULL
»	NULL
tot	NULL
tp	NULL
presence	NULL
(	NULL
PMA/I/CsA	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
PMA/I	NULL
)	NULL
of	NULL
0.1	NULL
mol/L	NULL
CsA	NULL
.	NULL

Bands	NULL
migrating	NULL
below	NULL
the	NULL
NFATp	NULL
and	NULL
NFAT	NULL
complexes	NULL
appear	NULL
to	NULL
represent	NULL
nonspecific	NULL
constitutive	NULL
factors	NULL
.	NULL

Where	NULL
indicated	NULL
,	NULL
assays	NULL
of	NULL
stimulated	NULL
C11STH	NULL
cell	NULL
nuclear	NULL
extract	NULL
binding	NULL
to	NULL
the	NULL
GM430	NULL
NFATp	NULL
and	NULL
IL-2	NULL
NFAT	NULL
probes	NULL
also	NULL
include	NULL
25	NULL
ng	NULL
duplex	NULL
oligonucleotides	NULL
corresponding	NULL
to	NULL
the	NULL
GM430	NULL
NFATp	NULL
site	NULL
,	NULL
the	NULL
IL-2	NULL
NFAT	NULL
site	NULL
,	NULL
or	NULL
an	NULL
unrelated	NULL
sequence	NULL
(	NULL
X	NULL
)	NULL
as	NULL
competitor	NULL
.	NULL

Each	NULL
assay	NULL
used	NULL
5	NULL
ug	NULL
protein	NULL
,	NULL
and	NULL
the	NULL
asterisk	NULL
indicates	NULL
one	NULL
lane	NULL
where	NULL
a	NULL
shorter	NULL
autoradiographic	NULL
exposure	NULL
was	NULL
included	NULL
to	NULL
assist	NULL
identification	NULL
of	NULL
the	NULL
NFATp	NULL
complex	NULL
in	NULL
the	NULL
Jurkat	NULL
extract	NULL
.	NULL

tas	NULL
ts	NULL
peared	NULL
as	NULL
a	NULL
constitutive	NULL
site	NULL
in	NULL
both	NULL
C11STH	NULL
cells	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
and	NULL
HUVEs	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

Although	NULL
not	NULL
detected	NULL
in	NULL
Jurkat	NULL
T	NULL
cells	NULL
,	NULL
this	NULL
site	NULL
also	NULL
appeared	NULL
as	NULL
a	NULL
DH	NULL
site	NULL
in	NULL
activated	NULL
T	NULL
lymphocytes	NULL
(	NULL
Fig	NULL
5B	NULL
)	NULL
.	NULL

The	NULL
DH	NULL
site	NULL
within	NULL
the	NULL
enhancer	NULL
appeared	NULL
as	NULL
a	NULL
weak	NULL
site	NULL
before	NULL
activation	NULL
and	NULL
was	NULL
strongly	NULL
induced	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
the	NULL
coactivators	NULL
PMA	NULL
and	NULL
A23187	NULL
in	NULL
both	NULL
C11STH	NULL
cells	NULL
and	NULL
HUVEs	NULL
.	NULL

The	NULL
DH	NULL
site	NULL
existed	NULL
as	NULL
a	NULL
broad	NULL
region	NULL
2.8	NULL
to	NULL
3.0	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
,	NULL
thus	NULL
resembling	NULL
the	NULL
DH	NULL
site	NULL
induced	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Significantly	NULL
,	NULL
induction	NULL
of	NULL
this	NULL
DH	NULL
site	NULL
was	NULL
reduced	NULL
by	NULL
about	NULL
70	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
0.1	NULL
mol/L	NULL
CsA	NULL
,	NULL
which	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
promoter	NULL
DH	NULL
site	NULL
(	NULL
Fig	NULL
5A	NULL
)	NULL
.	NULL

We	NULL
also	NULL
examined	NULL
endothelial	NULL
cells	NULL
activated	NULL
by	NULL
TNF-a	NULL
,	NULL
but	NULL
observed	NULL
that	NULL
this	NULL
cytokine	NULL
was	NULL
not	NULL
a	NULL
significant	NULL
inducer	NULL
of	NULL
any	NULL
DH	NULL
sites	NULL
within	NULL
the	NULL
GM-CSF	NULL
locus	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
GM-CSF	NULL
enhancer	NULL
contributes	NULL
to	NULL
GM-CSF	NULL
activation	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
whether	NULL
the	NULL
upstream	NULL
enhancer	NULL
was	NULL
required	NULL
for	NULL
efficient	NULL
GM-CSF	NULL
promoter	NULL
activation	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
the	NULL
enhancer	NULL
was	NULL
coupled	NULL
to	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
a	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmid	NULL
.	NULL

On	NULL
transfection	NULL
into	NULL
C11STH	NULL
cells	NULL
and	NULL
stimulation	NULL
with	NULL
the	NULL
coactivators	NULL
PMA	NULL
and	NULL
A23187	NULL
,	NULL
the	NULL
enhancer	NULL
supported	NULL
a	NULL
fivefold	NULL
greater	NULL
induction	NULL
of	NULL
luciferase	NULL
gene	NULL
expression	NULL
than	NULL
was	NULL
obtained	NULL
with	NULL
a	NULL
luciferase	NULL
gene	NULL
driven	NULL
by	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
alone	NULL
(	NULL
Fig	NULL
6	NULL
)	NULL
.	NULL

Furthermore	NULL
,	NULL
this	NULL
induction	NULL
was	NULL
suppressed	NULL
by	NULL
about	NULL
60	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

CsA	NULL
inhibits	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
activated	NULL
endothelial	NULL
cells	NULL
.	NULL

-	NULL
Having	NULL
found	NULL
that	NULL
CsA	NULL
could	NULL
suppress	NULL
cytokine	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
next	NULL
examined	NULL
whether	NULL
CsA	NULL
could	NULL
influence	NULL
neutrophil	NULL
adhesion	NULL
to	NULL
activated	NULL
endothelial	NULL
cells	NULL
.	NULL

Neutrophils	NULL
become	NULL
involved	NULL
at	NULL
the	NULL
earliest	NULL
stages	NULL
during	NULL
the	NULL
progression	NULL
of	NULL
inflammation	NULL
and	NULL
are	NULL
also	NULL
one	NULL
of	NULL
the	NULL
cell	NULL
types	NULL
activated	NULL
by	NULL
GM-CSF	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
TNF-a	NULL
,	NULL
we	NULL
observed	NULL
an	NULL
approximately	NULL
sixfold	NULL
increase	NULL
in	NULL
the	NULL
adherence	NULL
of	NULL
neutrophils	NULL
to	NULL
a	NULL
confluent	NULL
monolayer	NULL
of	NULL
C11STH	NULL
cells	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
,	NULL
we	NULL
observed	NULL
a	NULL
29	NULL
%	NULL
decrease	NULL
(	NULL
P	NULL
=	NULL
.0006	NULL
)	NULL
in	NULL
the	NULL
TNF-a-induced	NULL
neutrophil	NULL
adherence	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
AND	NULL
E-SELECTIN	NULL
GENE	NULL
EXPRESSION	NULL
800r	NULL
pg/ml	NULL
J	NULL
S	NULL
GM-CSF	NULL
e	NULL
§	NULL
0	NULL
NIL	NULL
-	NULL
PI	NULL
_	NULL
PIC	NULL
Fig	NULL
3	NULL
.	NULL

-	NULL
Suppression	NULL
of	NULL
GM-CSF	NULL
protein	NULL
synthesis	NULL
in	NULL
HUVEs	NULL
by	NULL
CsA	NULL
.	NULL

Levels	NULL
of	NULL
GM-CSF	NULL
secretion	NULL
by	NULL
cultured	NULL
HUVEs	NULL
were	NULL
measured	NULL
by	NULL
ELISA	NULL
.	NULL

Four	NULL
independent	NULL
lines	NULL
of	NULL
HUVEs	NULL
were	NULL
either	NULL
not	NULL
stimulated	NULL
(	NULL
NIL	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
16	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
umol/L	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
PIC	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
Pl	NULL
)	NULL
of	NULL
0.1	NULL
umol/L	NULL
CsA	NULL
.	NULL

Shown	NULL
above	NULL
are	NULL
the	NULL
mean	NULL
expression	NULL
levels	NULL
obtained	NULL
with	NULL
the	NULL
four	NULL
lines	NULL
of	NULL
HUVEs	NULL
together	NULL
with	NULL
error	NULL
bars	NULL
indicating	NULL
the	NULL
SEM	NULL
.	NULL

There	NULL
was	NULL
a	NULL
statistically	NULL
significant	NULL
mean	NULL
decrease	NULL
of	NULL
320	NULL
pg/mL	NULL
GM-CSF	NULL
(	NULL
SEM	NULL
=	NULL
132	NULL
,	NULL
P	NULL
<	NULL
.01	NULL
)	NULL
in	NULL
the	NULL
four	NULL
lines	NULL
of	NULL
HUVEs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

E-selectin	NULL
expression	NULL
is	NULL
suppressed	NULL
by	NULL
CsA	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

To	NULL
determine	NULL
which	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
on	NULL
endothelial	NULL
cells	NULL
might	NULL
be	NULL
suppressed	NULL
by	NULL
CsA	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
regulation	NULL
of	NULL
E-selectin	NULL
and	NULL
VCAM-1	NULL
expression	NULL
in	NULL
C11STH	NULL
cells	NULL
.	NULL

E-selectin	NULL
can	NULL
interact	NULL
with	NULL
receptors	NULL
on	NULL
neutrophils	NULL
,	NULL
eosinophils	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
subsets	NULL
of	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
an	NULL
important	NULL
regulator	NULL
of	NULL
both	NULL
acute	NULL
and	NULL
chronic	NULL
in-flammation	NULL
.	NULL

``	NULL
``	NULL
``	NULL
*	NULL
VCAM-1	NULL
plays	NULL
a	NULL
major	NULL
role	NULL
in	NULL
the	NULL
adherence	NULL
of	NULL
monocytes	NULL
and	NULL
lymphocytes	NULL
to	NULL
endothelial	NULL
cells	NULL
.	NULL
``	NULL

We	NULL
first	NULL
showed	NULL
that	NULL
E-selectin	NULL
was	NULL
induced	NULL
in	NULL
C11STH	NULL
cells	NULL
in	NULL
the	NULL
expected	NULL
fashion	NULL
by	NULL
either	NULL
TNF-a	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
PMA/I	NULL
)	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

IFN-y	NULL
alone	NULL
was	NULL
unable	NULL
to	NULL
induce	NULL
E-selectin	NULL
expression	NULL
,	NULL
but	NULL
greatly	NULL
enhanced	NULL
its	NULL
activation	NULL
by	NULL
TNF-a	NULL
.	NULL

We	NULL
also	NULL
observed	NULL
that	NULL
the	NULL
cAMP	NULL
inducer	NULL
forskolin	NULL
was	NULL
a	NULL
potent	NULL
inhibitor	NULL
of	NULL
TNF-	NULL
«	NULL
-inducible	NULL
E-selectin	NULL
expression	NULL
in	NULL
C11STH	NULL
cells	NULL
,	NULL
as	NULL
previously	NULL
observed	NULL
by	NULL
others	NULL
in	NULL
HUVEs	NULL
.	NULL
``	NULL

On	NULL
inclusion	NULL
of	NULL
increasing	NULL
amounts	NULL
of	NULL
CsA	NULL
,	NULL
we	NULL
observed	NULL
up	NULL
to	NULL
a	NULL
40	NULL
%	NULL
decrease	NULL
in	NULL
the	NULL
cell	NULL
surface	NULL
expression	NULL
of	NULL
E-selectin	NULL
expression	NULL
in	NULL
C1	NULL
1STH	NULL
cells	NULL
activated	NULL
by	NULL
either	NULL
TNF-	NULL
«	NULL
,	NULL
TNF-a	NULL
plus	NULL
IFN	NULL
,	NULL
or	NULL
PMA	NULL
and	NULL
A23187	NULL
(	NULL
Fig	NULL
7	NULL
)	NULL
.	NULL

CsA	NULL
reduced	NULL
the	NULL
expression	NULL
obtained	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
to	NULL
a	NULL
level	NULL
equivalent	NULL
to	NULL
that	NULL
obtained	NULL
with	NULL
PMA	NULL
alone	NULL
.	NULL

Furthermore	NULL
,	NULL
activation	NULL
of	NULL
E-selectin	NULL
expression	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
PMA	NULL
alone	NULL
was	NULL
essentially	NULL
resistant	NULL
to	NULL
the	NULL
effects	NULL
of	NULL
CsA	NULL
.	NULL

2693	NULL
Interestingly	NULL
,	NULL
CsA	NULL
also	NULL
did	NULL
not	NULL
suppress	NULL
the	NULL
component	NULL
of	NULL
TNF-a-inducible	NULL
E-selectin	NULL
expression	NULL
that	NULL
was	NULL
resistant	NULL
to	NULL
forskolin	NULL
.	NULL

The	NULL
effects	NULL
of	NULL
CsA	NULL
on	NULL
E-selectin	NULL
expression	NULL
appeared	NULL
to	NULL
be	NULL
specific	NULL
,	NULL
as	NULL
CsA	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
the	NULL
induction	NULL
of	NULL
VCAM-1	NULL
expression	NULL
by	NULL
any	NULL
of	NULL
the	NULL
above	NULL
agents	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

A	NULL
CsA-sensitive	NULL
DNasel	NULL
hypersensitive	NULL
site	NULL
exists	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
.	NULL

_	NULL
To	NULL
search	NULL
for	NULL
regulatory	NULL
elements	NULL
that	NULL
might	NULL
account	NULL
for	NULL
the	NULL
CsA-sensitivity	NULL
of	NULL
E-selectin	NULL
gene	NULL
expression	NULL
,	NULL
we	NULL
screened	NULL
the	NULL
E-selectin	NULL
locus	NULL
for	NULL
CsA-sensitive	NULL
DH	NULL
sites	NULL
.	NULL

For	NULL
this	NULL
purpose	NULL
we	NULL
reprobed	NULL
the	NULL
filter	NULL
used	NULL
in	NULL
Fig	NULL
5	NULL
with	NULL
an	NULL
intragenic	NULL
E-selectin	NULL
probe	NULL
.	NULL

DNaselI	NULL
digestion	NULL
of	NULL
the	NULL
E-selectin	NULL
chromosomal	NULL
locus	NULL
produced	NULL
additional	NULL
3.0-	NULL
and	NULL
6.5-kb	NULL
subfragments	NULL
of	NULL
the	NULL
9-kb	NULL
EcoRI	NULL
fragment	NULL
,	NULL
indicating	NULL
that	NULL
two	NULL
DH	NULL
sites	NULL
existed	NULL
upstream	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
in	NULL
activated	NULL
endothelial	NULL
cells	NULL
(	NULL
Fig	NULL
8	NULL
)	NULL
.	NULL

One	NULL
DH	NULL
site	NULL
near	NULL
the	NULL
origin	NULL
of	NULL
transcription	NULL
was	NULL
induced	NULL
by	NULL
either	NULL
TNF-a	NULL
or	NULL
a	NULL
combination	NULL
of	NULL
PMA	NULL
and	NULL
A23187	NULL
in	NULL
both	NULL
C11STH	NULL
cells	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
and	NULL
HUVEs	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
and	NULL
has	NULL
also	NULL
recently	NULL
been	NULL
detected	NULL
by	NULL
others	NULL
.	NULL
``	NULL

''	NULL
The	NULL
second	NULL
DH	NULL
site	NULL
,	NULL
located	NULL
3.5	NULL
kb	NULL
upstream	NULL
,	NULL
appeared	NULL
as	NULL
a	NULL
constitutive	NULL
DH	NULL
site	NULL
.	NULL

Significantly	NULL
,	NULL
the	NULL
inducible	NULL
but	NULL
not	NULL
the	NULL
constitutive	NULL
site	NULL
,	NULL
was	NULL
suppressed	NULL
by	NULL
CsA	NULL
(	NULL
Fig	NULL
8A	NULL
)	NULL
,	NULL
suggesting	NULL
that	NULL
CsA-sensitive	NULL
transcriptional	NULL
activation	NULL
ele-	NULL
[	NULL
HUVE	NULL
C11-STH	NULL
1	NULL
I	NULL
I	NULL
<	NULL
3	NULL
3	NULL
0	NULL
0	NULL
4	NULL
m	NULL
&	NULL
m	NULL
I	NULL
3	NULL
-	NULL
_-	NULL
o	NULL
8	NULL
n	NULL
s	NULL
gg	NULL
lg	NULL
$	NULL
s	NULL
6	NULL
z	NULL
E	NULL
E	NULL
E	NULL
1	NULL
E	NULL
&	NULL
F	NULL
-	NULL
GM-CSF	NULL
d	NULL
§	NULL
1	NULL
o	NULL
Ge	NULL
.	NULL

-	NULL
Acie	NULL
;	NULL
...	NULL
..	NULL
-	NULL
GAPDH	NULL
Fig	NULL
4	NULL
.	NULL

Suppression	NULL
of	NULL
GM-CSF	NULL
mRNA	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
CsA	NULL
.	NULL

RNA	NULL
was	NULL
isolated	NULL
from	NULL
HUVEs	NULL
and	NULL
C11STH	NULL
cells	NULL
that	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
Nil	NULL
)	NULL
,	NULL
stimulated	NULL
for	NULL
8	NULL
hours	NULL
with	NULL
20	NULL
ng/	NULL
mL	NULL
PMA	NULL
(	NULL
PMA	NULL
)	NULL
,	NULL
or	NULL
stimulated	NULL
for	NULL
8	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
pmol/L	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
PMA/I/CsA	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
PMA/I	NULL
)	NULL
of	NULL
0.1	NULL
umol/L	NULL
CsA	NULL
.	NULL

GM-CSF	NULL
mRNA	NULL
levels	NULL
were	NULL
assayed	NULL
by	NULL
RNase	NULL
protection	NULL
assay	NULL
,	NULL
using	NULL
GAPDH	NULL
as	NULL
an	NULL
internal	NULL
control	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2694	NULL
J	NULL
>	NULL
J	NULL
<	NULL
Z	NULL
A	NULL
C	NULL
Ex	NULL
=	NULL
0	NULL
@	NULL
P	NULL
/I	NULL
/	NULL
CsA	NULL
Jurkat	NULL
+	NULL
P	NULL
/	NULL
I	NULL
T	NULL
cell	NULL
+	NULL
P	NULL
/I	NULL
HUVE	NULL
+	NULL
Nil	NULL
HUVE	NULL
+P	NULL
/I	NULL
C	NULL
IL-3	NULL
Pit	NULL
”	NULL
Enhancer	NULL
GM-CSF	NULL
ﬂ	NULL
T	NULL
T	NULL
{	NULL
CO	NULL
}	NULL
—T_	NULL
EcoRl	NULL
_	NULL
EcoRI	NULL
g	NULL
t	NULL
EcoRI	NULL
Fig	NULL
5	NULL
.	NULL

Mapping	NULL
of	NULL
DH	NULL
sites	NULL
from	NULL
an	NULL
EcoRl	NULL
site	NULL
6.8	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
GM-CSF	NULL
gene	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
Nil	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
4	NULL
to	NULL
6	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
umol/	NULL
L	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
P/l/CsA	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
P/l	NULL
)	NULL
of	NULL
0.1	NULL
mol/L	NULL
CsA	NULL
.	NULL

(	NULL
A	NULL
)	NULL
shows	NULL
DH	NULL
sites	NULL
in	NULL
C11STH	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
these	NULL
sites	NULL
are	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNasel	NULL
digestion	NULL
(	NULL
control	NULL
DNA	NULL
)	NULL
.	NULL

P	NULL
represents	NULL
a	NULL
DH	NULL
site	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
,	NULL
whereas	NULL
E	NULL
represents	NULL
a	NULL
DH	NULL
site	NULL
located	NULL
in	NULL
the	NULL
center	NULL
of	NULL
the	NULL
enhancer	NULL
2.8	NULL
to	NULL
3.0	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

ments	NULL
existed	NULL
in	NULL
the	NULL
proximal	NULL
promoter	NULL
.	NULL

Both	NULL
DH	NULL
sites	NULL
appeared	NULL
to	NULL
be	NULL
endothelial	NULL
cell	NULL
specific	NULL
as	NULL
they	NULL
did	NULL
not	NULL
appear	NULL
in	NULL
activated	NULL
Jurkat	NULL
cells	NULL
or	NULL
T	NULL
cells	NULL
(	NULL
Fig	NULL
8B	NULL
)	NULL
or	NULL
in	NULL
a	NULL
wide	NULL
range	NULL
of	NULL
other	NULL
cell	NULL
types	NULL
examined	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

CsA	NULL
may	NULL
suppress	NULL
NF-KB	NULL
activity	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
.	NULL

We	NULL
examined	NULL
the	NULL
sequence	NULL
of	NULL
the	NULL
E-selectin	NULL
promoter	NULL
seeking	NULL
transcription	NULL
factor	NULL
binding	NULL
sites	NULL
that	NULL
might	NULL
be	NULL
involved	NULL
in	NULL
DH	NULL
site	NULL
formation	NULL
and	NULL
be	NULL
suppressed	NULL
by	NULL
CsA	NULL
.	NULL

Previous	NULL
studies	NULL
of	NULL
E-selectin	NULL
gene	NULL
regulation	NULL
have	NULL
implicated	NULL
an	NULL
array	NULL
of	NULL
three	NULL
NF-KB	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
as	NULL
being	NULL
crucial	NULL
for	NULL
activation	NULL
of	NULL
E-selectin	NULL
expression	NULL
,	NULL
``	NULL
and	NULL
these	NULL
sites	NULL
may	NULL
be	NULL
the	NULL
most	NULL
likely	NULL
targets	NULL
for	NULL
the	NULL
actions	NULL
of	NULL
CsA	NULL
in	NULL
this	NULL
locus	NULL
.	NULL

Indeed	NULL
,	NULL
there	NULL
is	NULL
some	NULL
evidence	NULL
that	NULL
NF-kB	NULL
p50	NULL
and	NULL
c-rel	NULL
expression	NULL
is	NULL
inhibitible	NULL
by	NULL
either	NULL
CsA	NULL
or	NULL
FK506	NULL
,	NULL
*5**	NULL
which	NULL
might	NULL
account	NULL
for	NULL
the	NULL
40	NULL
%	NULL
inhibition	NULL
of	NULL
E-selectin	NULL
expression	NULL
that	NULL
occurs	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

Nevertheless	NULL
,	NULL
there	NULL
is	NULL
also	NULL
evidence	NULL
obtained	NULL
with	NULL
T	NULL
cells	NULL
that	NULL
NFAT-like	NULL
factors	NULL
can	NULL
in	NULL
some	NULL
cases	NULL
associate	NULL
with	NULL
NF-kB-like	NULL
regulatory	NULL
regions	NULL
.	NULL
``	NULL

To	NULL
determine	NULL
whether	NULL
NFAT	NULL
or	NULL
NF-kB	NULL
proteins	NULL
are	NULL
more	NULL
likely	NULL
to	NULL
account	NULL
for	NULL
the	NULL
CsA-sensitivity	NULL
of	NULL
E-selectin	NULL
expression	NULL
,	NULL
we	NULL
examined	NULL
binding	NULL
of	NULL
recombinant	NULL
NFATp	NULL
,	NULL
NF-kB	NULL
COCKERILL	NULL
ET	NULL
AL	NULL
GM-CSF	NULL
PROMOTER	NULL
+	NULL
ENHANCER	NULL
100	NULL
1	NULL
p	NULL
E	NULL
ag	NULL
6	NULL
715	NULL
|	NULL
<	NULL
E	NULL
,	NULL
®	NULL
so	NULL
|	NULL
G	NULL
3	NULL
GM-CSF	NULL
m	NULL
PROMOTER	NULL
2A	NULL
2s	NULL
|	NULL
5	NULL
2	NULL
€	NULL
NIL	NULL
PMA	NULL
PMA	NULL
I	NULL
I	NULL
I	NULL
I	NULL
CsA	NULL
CsA	NULL
NIL	NULL
PMA	NULL
PMA	NULL
Fig	NULL
6	NULL
.	NULL

Activation	NULL
of	NULL
GM-CSF	NULL
enhancer/promoter	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Luciferase	NULL
gene	NULL
plasmids	NULL
containing	NULL
either	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
(	NULL
pGMIluc	NULL
)	NULL
or	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
linked	NULL
to	NULL
the	NULL
promoter	NULL
(	NULL
pGMEluc	NULL
)	NULL
were	NULL
transfected	NULL
into	NULL
C11STH	NULL
cells	NULL
and	NULL
stimulated	NULL
for	NULL
9	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
mol/L	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
PMA/I/CsA	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
PMA/I	NULL
)	NULL
of	NULL
0.1	NULL
mol/L	NULL
CsA	NULL
.	NULL

Luciferase	NULL
activities	NULL
were	NULL
expressed	NULL
as	NULL
a	NULL
percentage	NULL
of	NULL
the	NULL
values	NULL
obtained	NULL
with	NULL
stimulated	NULL
pGME	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
of	NULL
nine	NULL
experiments	NULL
.	NULL

Error	NULL
bars	NULL
represent	NULL
the	NULL
standard	NULL
deviation	NULL
.	NULL

p50	NULL
,	NULL
and	NULL
NF-kB	NULL
p65	NULL
to	NULL
the	NULL
best	NULL
characterized	NULL
NF-KB	NULL
site	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
(	NULL
PDI®	NULL
)	NULL
,	NULL
and	NULL
to	NULL
three	NULL
control	NULL
NFATp	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
sites	NULL
(	NULL
Fig	NULL
9	NULL
)	NULL
.	NULL

This	NULL
particular	NULL
E-selectin	NULL
NF-KB	NULL
site	NULL
was	NULL
the	NULL
most	NULL
proximal	NULL
of	NULL
the	NULL
three	NULL
NF-KB	NULL
sites	NULL
in	NULL
the	NULL
promoter	NULL
and	NULL
the	NULL
one	NULL
found	NULL
to	NULL
be	NULL
the	NULL
most	NULL
essential	NULL
for	NULL
E-selectin	NULL
promoter	NULL
activity	NULL
.	NULL

As	NULL
this	NULL
element	NULL
encompasses	NULL
the	NULL
sequence	NULL
AGAGGAAA	NULL
,	NULL
it	NULL
is	NULL
also	NULL
the	NULL
E-selectin	NULL
NF-KB	NULL
site	NULL
that	NULL
most	NULL
resembles	NULL
binding	NULL
sites	NULL
for	NULL
NFATp.®°	NULL
As	NULL
anticipated	NULL
from	NULL
earlier	NULL
studies	NULL
of	NULL
T-cell	NULL
nuclear	NULL
ex-tracts	NULL
,	NULL
``	NULL
both	NULL
the	NULL
IL-2	NULL
NFAT	NULL
site	NULL
and	NULL
the	NULL
Igk	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
had	NULL
the	NULL
capacity	NULL
to	NULL
associate	NULL
with	NULL
all	NULL
three	NULL
proteins	NULL
.	NULL

This	NULL
confirmed	NULL
the	NULL
view	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
NFATp	NULL
have	NULL
the	NULL
poten-	NULL
Table	NULL
1	NULL
.	NULL

Suppression	NULL
of	NULL
Neutrophil	NULL
Adhesion	NULL
to	NULL
C11STH	NULL
Cells	NULL
by	NULL
CsA	NULL
Treatment	NULL
Adhesion	NULL
(	NULL
cpm	NULL
x	NULL
10	NULL
°	NULL
)	NULL
Nil	NULL
117	NULL
+	NULL
7	NULL
(	NULL
n	NULL
=	NULL
7	NULL
)	NULL
TNF-a	NULL
795	NULL
+	NULL
33	NULL
(	NULL
n	NULL
=	NULL
14	NULL
)	NULL
TNF-a/CsA	NULL
565	NULL
+	NULL
49	NULL
(	NULL
n	NULL
=	NULL
9	NULL
)	NULL
Results	NULL
are	NULL
presented	NULL
as	NULL
mean	NULL
+	NULL
SEM	NULL
.	NULL

The	NULL
29	NULL
%	NULL
decrease	NULL
in	NULL
neutrophil	NULL
adhesion	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
was	NULL
statistically	NULL
significant	NULL
as	NULL
a	NULL
Student	NULL
's	NULL
t-test	NULL
gave	NULL
P	NULL
=	NULL
.0006	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
AND	NULL
E-SELECTIN	NULL
GENE	NULL
EXPRESSION	NULL
30	NULL
Fig	NULL
7	NULL
.	NULL

CsA	NULL
suppresses	NULL
induction	NULL
of	NULL
E-selectin	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

E-selectin	NULL
expression	NULL
was	NULL
induced	NULL
in	NULL
C11STH	NULL
cells	NULL
as	NULL
indicated	NULL
above	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
increasing	NULL
concentrations	NULL
of	NULL
CsA	NULL
,	NULL
which	NULL
was	NULL
added	NULL
10	NULL
minutes	NULL
before	NULL
stimulation	NULL
of	NULL
the	NULL
cells	NULL
.	NULL

See	NULL
Materials	NULL
and	NULL
Methods	NULL
for	NULL
activation	NULL
con-ditions	NULL
.	NULL

20	NULL
10	NULL
MEAN	NULL
FLUORESCENCE	NULL
INTENSITY	NULL
Nil	NULL
IFN	NULL
CsA	NULL
(	NULL
uM	NULL
)	NULL
0	NULL
0	NULL
tial	NULL
to	NULL
cross-compete	NULL
for	NULL
binding	NULL
sites	NULL
.	NULL

However	NULL
,	NULL
the	NULL
E-selectin	NULL
NF-kB	NULL
site	NULL
exhibited	NULL
the	NULL
weakest	NULL
relative	NULL
affinity	NULL
for	NULL
NFATp	NULL
,	NULL
while	NULL
efficiently	NULL
binding	NULL
both	NULL
p50	NULL
and	NULL
p65	NULL
.	NULL

Hence	NULL
,	NULL
although	NULL
NFATp	NULL
did	NULL
have	NULL
limited	NULL
potential	NULL
to	NULL
bind	NULL
the	NULL
E-selectin	NULL
NF-KB	NULL
site	NULL
,	NULL
it	NULL
appeared	NULL
less	NULL
likely	NULL
than	NULL
NF-kB	NULL
to	NULL
play	NULL
a	NULL
major	NULL
role	NULL
in	NULL
its	NULL
regulation	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
very	NULL
little	NULL
NF-kB	NULL
p50	NULL
or	NULL
p65	NULL
binding	NULL
was	NULL
detected	NULL
with	NULL
the	NULL
GM430	NULL
A	NULL
B	NULL
3	NULL
<	NULL
re	NULL
3	NULL
Co-	NULL
Z	NULL
,	NULL
+	NULL
Z	NULL
,	NULL
-	NULL
_	NULL
A	NULL
:	NULL
f++tf=~m	NULL
cC	NULL
C	NULL
3	NULL
m	NULL
m	NULL
m	NULL
m	NULL
£	NULL
*	NULL
B	NULL
~	NULL
:	NULL
'	NULL
as	NULL
?	NULL
)	NULL

U	NULL
Z	NULL
a	NULL
o	NULL
H	NULL
AR	NULL
ARR	NULL
5	NULL
E	NULL
6.5	NULL
>	NULL
6.5	NULL
>	NULL
m+5.0	NULL
.	NULL

“	NULL
3.0	NULL
>	NULL
«	NULL
E-selectin	NULL
gene	NULL
EcoRI	NULL
DNasel	NULL
DNiseI	NULL
Bglll	NULL
EcoRI	NULL
|	NULL
T	NULL
~T	NULL
-6.0	NULL
-3.5	NULL
0	NULL
+1.3	NULL
_	NULL
+3.0	NULL
<	NULL
-probe	NULL
Fig	NULL
8	NULL
.	NULL

Mapping	NULL
of	NULL
DH	NULL
sites	NULL
upstream	NULL
of	NULL
the	NULL
E-selectin	NULL
gene	NULL
in	NULL
endothelial	NULL
cells	NULL
from	NULL
an	NULL
EcoRl	NULL
site	NULL
3.0	NULL
kb	NULL
upstream	NULL
of	NULL
the	NULL
transcription	NULL
start	NULL
site	NULL
.	NULL

Cells	NULL
were	NULL
either	NULL
unstimulated	NULL
(	NULL
Nil	NULL
)	NULL
or	NULL
stimulated	NULL
for	NULL
4	NULL
to	NULL
6	NULL
hours	NULL
with	NULL
20	NULL
ng/mL	NULL
PMA	NULL
and	NULL
2	NULL
umol/L	NULL
A23187	NULL
in	NULL
the	NULL
presence	NULL
(	NULL
P/1/CsA	NULL
)	NULL
or	NULL
absence	NULL
(	NULL
P/l	NULL
)	NULL
of	NULL
0.1	NULL
wmol/L	NULL
CsA	NULL
or	NULL
with	NULL
100	NULL
U/mL	NULL
TNF-	NULL
«	NULL
.	NULL

(	NULL
A	NULL
)	NULL
shows	NULL
DH	NULL
sites	NULL
in	NULL
C11STH	NULL
cells	NULL
.	NULL

Note	NULL
that	NULL
these	NULL
sites	NULL
are	NULL
not	NULL
detected	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
DNasel	NULL
digestion	NULL
(	NULL
control	NULL
DNA	NULL
)	NULL
.	NULL

The	NULL
inducible	NULL
DH	NULL
site	NULL
in	NULL
the	NULL
proximal	NULL
region	NULL
of	NULL
the	NULL
promoter	NULL
appeared	NULL
as	NULL
a	NULL
3.0-kb	NULL
fragment	NULL
,	NULL
whereas	NULL
an	NULL
upstream	NULL
constitutive	NULL
DH	NULL
site	NULL
appeared	NULL
as	NULL
a	NULL
6.5-kb	NULL
fragment	NULL
.	NULL

The	NULL
membranes	NULL
used	NULL
in	NULL
(	NULL
A	NULL
)	NULL
and	NULL
(	NULL
B	NULL
)	NULL
are	NULL
the	NULL
same	NULL
as	NULL
those	NULL
in	NULL
Fig	NULL
3	NULL
.	NULL

0	NULL
0.01	NULL
0.1	NULL
2695	NULL
TNF	NULL
Forskolin	NULL
0	NULL
0.01	NULL
0.1	NULL
1	NULL
0	NULL
0.01	NULL
0.1	NULL
1	NULL
_	NULL
0	NULL
0.01	NULL
0.1	NULL
1	NULL
0	NULL
0.01	NULL
0.1	NULL
1	NULL
probe	NULL
,	NULL
which	NULL
is	NULL
a	NULL
high-affinity	NULL
NFAT	NULL
p	NULL
site	NULL
,	NULL
and	NULL
the	NULL
dominant	NULL
NFAT	NULL
site	NULL
in	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
.	NULL
``	NULL

DISCUSSION	NULL
To	NULL
gain	NULL
new	NULL
insights	NULL
into	NULL
processes	NULL
that	NULL
regulate	NULL
inflammation	NULL
,	NULL
we	NULL
focused	NULL
on	NULL
the	NULL
endothelium	NULL
,	NULL
which	NULL
orchestrates	NULL
IL-2	NULL
Igk	NULL
E-selectin	NULL
GM430	NULL
NFAT	NULL
NF-kB	NULL
NF-kB	NULL
NFATp	NULL
NF-kB	NULL
p50	NULL
NFAT	NULL
p	NULL
NFATp	NULL
NF-kB	NULL
p65	NULL
ce	NULL
,	NULL
z	NULL
z	NULL
NF-kB	NULL
p6	NULL
NF-kB	NULL
p5	NULL
Fig	NULL
9	NULL
.	NULL

Gel	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assays	NULL
of	NULL
recombinant	NULL
NFATp	NULL
and	NULL
NF-B	NULL
.	NULL

The	NULL
indicated	NULL
probes	NULL
were	NULL
incubated	NULL
with	NULL
0.5	NULL
ng	NULL
NFATp	NULL
,	NULL
10	NULL
ng	NULL
NF-	NULL
«	NULL
B	NULL
p50	NULL
,	NULL
or	NULL
0.07	NULL
uL	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
.	NULL

The	NULL
probes	NULL
corresponded	NULL
to	NULL
the	NULL
IL-2	NULL
promoter	NULL
distal	NULL
NFAT	NULL
site	NULL
,	NULL
``	NULL
``	NULL
the	NULL
x	NULL
Ig	NULL
gene	NULL
NF-kB	NULL
site	NULL
,	NULL
``	NULL
``	NULL
the	NULL
E-selectin	NULL
promoter	NULL
proximal	NULL
NF-B	NULL
site	NULL
,	NULL
``	NULL
and	NULL
the	NULL
GM430	NULL
high-affinity	NULL
NFATp	NULL
site	NULL
from	NULL
the	NULL
GM-CSF	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2696	NULL
many	NULL
early	NULL
inflammatory	NULL
events	NULL
,	NULL
and	NULL
CsA	NULL
,	NULL
which	NULL
is	NULL
in	NULL
widespread	NULL
use	NULL
as	NULL
an	NULL
immunosuppressive	NULL
and	NULL
antiinflammatory	NULL
drug	NULL
.	NULL

Two	NULL
important	NULL
classes	NULL
of	NULL
molecules	NULL
that	NULL
are	NULL
activated	NULL
during	NULL
the	NULL
early	NULL
stages	NULL
of	NULL
inflammation	NULL
are	NULL
the	NULL
cytokines	NULL
and	NULL
adhesion	NULL
molecules	NULL
that	NULL
direct	NULL
the	NULL
activation	NULL
and	NULL
trafficking	NULL
of	NULL
leukocytes	NULL
that	NULL
enter	NULL
inflammatory	NULL
lesions	NULL
.	NULL

We	NULL
have	NULL
concentrated	NULL
on	NULL
GM-CSF	NULL
and	NULL
E-selectin	NULL
as	NULL
potential	NULL
targets	NULL
for	NULL
antiinflammatory	NULL
actions	NULL
of	NULL
CsA	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
these	NULL
are	NULL
two	NULL
molecules	NULL
that	NULL
might	NULL
function	NULL
in	NULL
concert	NULL
on	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
.	NULL

Surprisingly	NULL
,	NULL
we	NULL
discovered	NULL
that	NULL
immunoregulatory	NULL
mechanisms	NULL
initially	NULL
thought	NULL
to	NULL
be	NULL
restricted	NULL
to	NULL
lymphoid	NULL
cells	NULL
also	NULL
operated	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

Hence	NULL
,	NULL
the	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFAT	NULL
was	NULL
induced	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
pathways	NULL
that	NULL
in	NULL
T	NULL
cells	NULL
are	NULL
triggered	NULL
by	NULL
T-cell	NULL
receptor	NULL
and	NULL
phospholipase	NULL
C	NULL
activation	NULL
.	NULL

CsA	NULL
,	NULL
an	NULL
immunosuppressant	NULL
previously	NULL
thought	NULL
to	NULL
function	NULL
primarily	NULL
by	NULL
inhibiting	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
also	NULL
inhibited	NULL
activation	NULL
of	NULL
NFAT	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

The	NULL
endothelial	NULL
cell	NULL
NFAT	NULL
complexes	NULL
were	NULL
found	NULL
to	NULL
contain	NULL
the	NULL
protein	NULL
NFATp	NULL
,	NULL
which	NULL
has	NULL
recently	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
expressed	NULL
in	NULL
both	NULL
hematopoietic	NULL
and	NULL
nonhematopoietic	NULL
cells	NULL
,	NULL
``	NULL
rather	NULL
than	NULL
NFATc	NULL
,	NULL
which	NULL
is	NULL
thought	NULL
to	NULL
be	NULL
lymphoid-spe-cific	NULL
.	NULL

Although	NULL
there	NULL
are	NULL
few	NULL
previous	NULL
reports	NULL
suggesting	NULL
functions	NULL
for	NULL
NFAT	NULL
outside	NULL
of	NULL
the	NULL
T-cell	NULL
lineage	NULL
,	NULL
a	NULL
recent	NULL
study	NULL
has	NULL
implicated	NULL
NFAT	NULL
as	NULL
a	NULL
factor	NULL
required	NULL
for	NULL
TNF-a	NULL
gene	NULL
expression	NULL
in	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

Other	NULL
studies	NULL
have	NULL
demonstrated	NULL
that	NULL
ligation	NULL
of	NULL
surface	NULL
immunoglobulin	NULL
results	NULL
in	NULL
CsA-sensitive	NULL
induction	NULL
of	NULL
NFAT	NULL
and	NULL
activation	NULL
of	NULL
NFAT	NULL
-responsive	NULL
reporter	NULL
genes	NULL
in	NULL
B	NULL
cells	NULL
.	NULL
``	NULL

GM-CSF	NULL
is	NULL
a	NULL
proinflammatory	NULL
cytokine	NULL
having	NULL
the	NULL
potential	NULL
to	NULL
activate	NULL
neutrophils	NULL
,	NULL
monocytes	NULL
,	NULL
and	NULL
eosinophils	NULL
.	NULL

Of	NULL
all	NULL
the	NULL
cytokines	NULL
that	NULL
can	NULL
be	NULL
expressed	NULL
by	NULL
endothelial	NULL
cells	NULL
,	NULL
GM-CSF	NULL
is	NULL
perhaps	NULL
the	NULL
only	NULL
one	NULL
strongly	NULL
inhibited	NULL
by	NULL
CsA	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
we	NULL
have	NULL
explored	NULL
the	NULL
potential	NULL
of	NULL
CsA	NULL
to	NULL
act	NULL
as	NULL
an	NULL
antiinflammatory	NULL
agent	NULL
working	NULL
to	NULL
suppress	NULL
activation	NULL
of	NULL
myeloid	NULL
cells	NULL
by	NULL
GM-CSF	NULL
.	NULL

We	NULL
observed	NULL
that	NULL
CsA	NULL
suppressed	NULL
the	NULL
Ca**-mediated	NULL
activation	NULL
of	NULL
GM-CSF	NULL
protein	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
50	NULL
%	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
expression	NULL
by	NULL
approximately	NULL
60	NULL
%	NULL
.	NULL

To	NULL
determine	NULL
the	NULL
molecular	NULL
basis	NULL
for	NULL
the	NULL
regulation	NULL
of	NULL
GM-CSF	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
we	NULL
examined	NULL
the	NULL
functions	NULL
of	NULL
regulatory	NULL
elements	NULL
within	NULL
the	NULL
GM-CSF	NULL
locus	NULL
.	NULL

Previous	NULL
studies	NULL
in	NULL
T	NULL
cells	NULL
suggested	NULL
that	NULL
GM-CSF	NULL
gene	NULL
activation	NULL
is	NULL
mediated	NULL
to	NULL
a	NULL
large	NULL
extent	NULL
by	NULL
binding	NULL
of	NULL
NFAT	NULL
to	NULL
the	NULL
upstream	NULL
enhancer	NULL
,	NULL
*°	NULL
and	NULL
binding	NULL
of	NULL
NFAT	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
to	NULL
the	NULL
promoter	NULL
.	NULL
``	NULL

In	NULL
this	NULL
study	NULL
we	NULL
found	NULL
that	NULL
the	NULL
upstream	NULL
enhancer	NULL
was	NULL
also	NULL
required	NULL
for	NULL
efficient	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
transfected	NULL
endothelial	NULL
cells	NULL
,	NULL
and	NULL
that	NULL
the	NULL
activity	NULL
of	NULL
the	NULL
promoter	NULL
and	NULL
enhancer	NULL
was	NULL
suppressed	NULL
twofold	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
.	NULL

As	NULL
seen	NULL
previously	NULL
in	NULL
T	NULL
cells	NULL
,	NULL
stimulation	NULL
with	NULL
PMA	NULL
and	NULL
A23187	NULL
led	NULL
to	NULL
chromatin	NULL
structure	NULL
changes	NULL
within	NULL
the	NULL
enhancer	NULL
that	NULL
were	NULL
suppressed	NULL
by	NULL
CsA	NULL
.	NULL

These	NULL
observations	NULL
may	NULL
suggest	NULL
a	NULL
direct	NULL
role	NULL
for	NULL
NFAT	NULL
in	NULL
the	NULL
induction	NULL
of	NULL
the	NULL
GM-CSF	NULL
enhancer	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

In	NULL
contrast	NULL
to	NULL
T	NULL
cells	NULL
,	NULL
endothelial	NULL
cells	NULL
appeared	NULL
to	NULL
have	NULL
only	NULL
a	NULL
partial	NULL
dependence	NULL
on	NULL
NFAT	NULL
for	NULL
induction	NULL
of	NULL
GM-CSF	NULL
expression	NULL
.	NULL

Although	NULL
CsA	NULL
completely	NULL
suppressed	NULL
in	NULL
COCKERILL	NULL
ET	NULL
AL	NULL
duction	NULL
of	NULL
NFAT	NULL
,	NULL
it	NULL
only	NULL
partially	NULL
suppressed	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
and	NULL
enhancer	NULL
and	NULL
GM-CSF	NULL
mRNA	NULL
and	NULL
protein	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

In	NULL
T	NULL
cells	NULL
,	NULL
CsA	NULL
essentially	NULL
eliminates	NULL
GM-CSF	NULL
gene	NULL
expression	NULL
.	NULL
``	NULL

Furthermore	NULL
,	NULL
TNF-a	NULL
was	NULL
a	NULL
potent	NULL
inducer	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
GM-CSF	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
but	NULL
was	NULL
a	NULL
poor	NULL
activator	NULL
of	NULL
NFAT	NULL
and	NULL
an	NULL
inefficient	NULL
inducer	NULL
of	NULL
the	NULL
DH	NULL
site	NULL
in	NULL
the	NULL
enhancer	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Therefore	NULL
,	NULL
it	NULL
is	NULL
likely	NULL
that	NULL
TNF-a	NULL
induces	NULL
GM-CSF	NULL
expression	NULL
by	NULL
using	NULL
factors	NULL
that	NULL
activate	NULL
the	NULL
promoter	NULL
in	NULL
the	NULL
absence	NULL
of	NULL
NFAT	NULL
.	NULL

Interestingly	NULL
,	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
existed	NULL
as	NULL
a	NULL
constitutive	NULL
DH	NULL
site	NULL
in	NULL
endothelial	NULL
cells	NULL
(	NULL
Fig	NULL
5	NULL
)	NULL
,	NULL
but	NULL
not	NULL
in	NULL
T	NULL
cells	NULL
``	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Consequently	NULL
,	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
may	NULL
exist	NULL
in	NULL
a	NULL
primed	NULL
state	NULL
in	NULL
cultured	NULL
endothelial	NULL
cells	NULL
and	NULL
have	NULL
a	NULL
reduced	NULL
dependence	NULL
on	NULL
the	NULL
enhancer	NULL
for	NULL
its	NULL
activation	NULL
.	NULL

We	NULL
also	NULL
found	NULL
some	NULL
evidence	NULL
suggesting	NULL
that	NULL
CsA	NULL
can	NULL
inhibit	NULL
endothelial	NULL
cell	NULL
functions	NULL
by	NULL
suppressing	NULL
factors	NULL
other	NULL
than	NULL
NFAT	NULL
.	NULL

E-selectin	NULL
expression	NULL
was	NULL
inhibited	NULL
by	NULL
about	NULL
40	NULL
%	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
CsA	NULL
by	NULL
a	NULL
process	NULL
unlikely	NULL
to	NULL
directly	NULL
involve	NULL
NFAT	NULL
.	NULL

The	NULL
E-selectin	NULL
promoter	NULL
is	NULL
activated	NULL
principally	NULL
by	NULL
an	NULL
array	NULL
of	NULL
NF-KB	NULL
sites	NULL
,	NULL
``	NULL
``	NULL
which	NULL
represented	NULL
poor	NULL
binding	NULL
sites	NULL
for	NULL
NFATp	NULL
.	NULL

Furthermore	NULL
,	NULL
the	NULL
suppression	NULL
of	NULL
E-selectin	NULL
by	NULL
CsA	NULL
was	NULL
not	NULL
limited	NULL
to	NULL
activation	NULL
pathways	NULL
involving	NULL
Ca	NULL
``	NULL
*	NULL
.	NULL

CsA	NULL
reduced	NULL
E-selectin	NULL
expression	NULL
by	NULL
the	NULL
same	NULL
extent	NULL
regardless	NULL
of	NULL
whether	NULL
TNF-a	NULL
or	NULL
PMA/A23187	NULL
was	NULL
used	NULL
to	NULL
induce	NULL
expression	NULL
.	NULL

This	NULL
was	NULL
in	NULL
marked	NULL
contrast	NULL
to	NULL
the	NULL
GM-CSF	NULL
gene	NULL
,	NULL
which	NULL
was	NULL
suppressed	NULL
by	NULL
CsA	NULL
when	NULL
activated	NULL
by	NULL
PMA/A23187	NULL
,	NULL
but	NULL
not	NULL
when	NULL
activated	NULL
by	NULL
TNF-a	NULL
.	NULL

CsA	NULL
also	NULL
suppressed	NULL
induction	NULL
of	NULL
the	NULL
DH	NULL
site	NULL
that	NULL
forms	NULL
over	NULL
the	NULL
array	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
sites	NULL
in	NULL
the	NULL
E-selectin	NULL
promoter	NULL
,	NULL
suggesting	NULL
that	NULL
CsA	NULL
may	NULL
regulate	NULL
members	NULL
of	NULL
the	NULL
NF-kB	NULL
family	NULL
in	NULL
endothelial	NULL
cells	NULL
.	NULL

This	NULL
suggestion	NULL
is	NULL
supported	NULL
by	NULL
reports	NULL
that	NULL
CsA	NULL
and	NULL
FK506	NULL
can	NULL
partially	NULL
suppress	NULL
two	NULL
NF-kB	NULL
family	NULL
members	NULL
in	NULL
lymphoid	NULL
celis	NULL
.	NULL

**	NULL
``	NULL
Indeed	NULL
,	NULL
the	NULL
NF-kB	NULL
p105/p50	NULL
gene	NULL
promoter	NULL
``	NULL
may	NULL
itself	NULL
be	NULL
regulated	NULL
by	NULL
CsA	NULL
,	NULL
as	NULL
it	NULL
includes	NULL
the	NULL
sequence	NULL
TGGACCGCATGA-CTCTA	NULL
that	NULL
closely	NULL
resembles	NULL
the	NULL
NFAT	NULL
consensus	NULL
se-quence	NULL
.	NULL
``	NULL

Alternatively	NULL
,	NULL
CsA	NULL
may	NULL
suppress	NULL
E-selectin	NULL
expression	NULL
at	NULL
the	NULL
posttranscriptional	NULL
level	NULL
,	NULL
thus	NULL
accounting	NULL
for	NULL
the	NULL
ability	NULL
of	NULL
CsA	NULL
to	NULL
suppress	NULL
distinct	NULL
pathways	NULL
to	NULL
the	NULL
same	NULL
extent	NULL
.	NULL

However	NULL
,	NULL
E-selectin	NULL
induction	NULL
via	NULL
PMA	NULL
was	NULL
not	NULL
significantly	NULL
influenced	NULL
by	NULL
CsA	NULL
,	NULL
arguing	NULL
against	NULL
a	NULL
posttranscriptional	NULL
mechanism	NULL
.	NULL

The	NULL
evidence	NULL
accumulated	NULL
in	NULL
this	NULL
study	NULL
suggests	NULL
that	NULL
the	NULL
ability	NULL
of	NULL
CsA	NULL
to	NULL
act	NULL
as	NULL
an	NULL
antiinflammatory	NULL
drug	NULL
may	NULL
be	NULL
partly	NULL
caused	NULL
by	NULL
direct	NULL
effects	NULL
on	NULL
the	NULL
endothelium	NULL
.	NULL

Although	NULL
immune	NULL
and	NULL
inflammatory	NULL
disorders	NULL
clearly	NULL
involve	NULL
complex	NULL
cytokine	NULL
networks	NULL
operating	NULL
within	NULL
a	NULL
confederacy	NULL
of	NULL
immune	NULL
and	NULL
nonimmune	NULL
cell	NULL
types	NULL
,	NULL
there	NULL
is	NULL
a	NULL
significant	NULL
role	NULL
that	NULL
the	NULL
endothelium	NULL
plays	NULL
in	NULL
their	NULL
progression	NULL
.	NULL

By	NULL
suppressing	NULL
GM-CSF	NULL
and	NULL
E-selectin	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
,	NULL
CsA	NULL
could	NULL
reduce	NULL
the	NULL
extent	NULL
to	NULL
which	NULL
neutrophils	NULL
and	NULL
eosinophils	NULL
are	NULL
recruited	NULL
at	NULL
sites	NULL
of	NULL
inflammation	NULL
.	NULL

In	NULL
this	NULL
study	NULL
,	NULL
the	NULL
effective	NULL
dose	NULL
of	NULL
CsA	NULL
(	NULL
0.1	NULL
umol/L	NULL
)	NULL
was	NULL
well	NULL
within	NULL
the	NULL
range	NULL
of	NULL
the	NULL
plasma	NULL
concentration	NULL
of	NULL
approximately	NULL
0.3	NULL
Lmol/L	NULL
CsA	NULL
that	NULL
is	NULL
usually	NULL
maintained	NULL
therapeuti-cally	NULL
.	NULL

Hence	NULL
,	NULL
this	NULL
study	NULL
may	NULL
,	NULL
in	NULL
part	NULL
,	NULL
account	NULL
for	NULL
the	NULL
reduction	NULL
in	NULL
neutrophil	NULL
and	NULL
eosinophil	NULL
infiltration	NULL
observed	NULL
on	NULL
treatment	NULL
of	NULL
disorders	NULL
such	NULL
as	NULL
and	NULL
asthma	NULL
``	NULL
with	NULL
CsA	NULL
.	NULL

From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

GM-CSF	NULL
AND	NULL
E-SELECTIN	NULL
GENE	NULL
EXPRESSION	NULL
ACKNOWLEDGMENT	NULL
We	NULL
are	NULL
indebted	NULL
to	NULL
A.	NULL
Rao	NULL
for	NULL
providing	NULL
NFATp	NULL
anti-sera	NULL
and	NULL
DNA	NULL
clones	NULL
for	NULL
NFATp	NULL
,	NULL
Y.	NULL
Khew-Goodall	NULL
for	NULL
the	NULL
E-selectin	NULL
NF-xB	NULL
probe	NULL
,	NULL
and	NULL
T.	NULL
Collins	NULL
for	NULL
providing	NULL
E-selectin	NULL
DNA	NULL
clones	NULL
.	NULL

We	NULL
thank	NULL
R.	NULL
Himes	NULL
,	NULL
F.	NULL
Jenkins	NULL
,	NULL
and	NULL
F.	NULL
Shannon	NULL
for	NULL
the	NULL
luciferase	NULL
reporter	NULL
gene	NULL
plasmids	NULL
.	NULL

We	NULL
thank	NULL
L.	NULL
Noack	NULL
for	NULL
technical	NULL
assistance	NULL
with	NULL
neutrophil	NULL
adhesion	NULL
assays	NULL
and	NULL
B.	NULL
Stein	NULL
for	NULL
assistance	NULL
with	NULL
statistical	NULL
analyses	NULL
.	NULL

We	NULL
thank	NULL
D.	NULL
Gillis	NULL
,	NULL
Y.	NULL
Khew-Goodall	NULL
,	NULL
and	NULL
MF	NULL
.	NULL

Shannon	NULL
for	NULL
helpful	NULL
advice	NULL
and	NULL
critical	NULL
reading	NULL
of	NULL
the	NULL
manu-script	NULL
.	NULL

REFERENCES	NULL
1	NULL
.	NULL

Masuda	NULL
ES	NULL
,	NULL
Naito	NULL
Y	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
Expression	NULL
of	NULL
lymphokine	NULL
genes	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

The	NULL
Immunologist	NULL
1:198	NULL
,	NULL
1993	NULL
2	NULL
.	NULL

Nicola	NULL
NA	NULL
:	NULL
Hemopoietic	NULL
cell	NULL
growth	NULL
factors	NULL
and	NULL
their	NULL
recep-tors	NULL
.	NULL

Annu	NULL
Rev	NULL
Biochem	NULL
58:45	NULL
,	NULL
1989	NULL
3	NULL
.	NULL

Mattila	NULL
PS	NULL
,	NULL
Ullman	NULL
KS	NULL
,	NULL
Fiering	NULL
S	NULL
,	NULL
Emme	NULL
!	NULL

EA	NULL
,	NULL
McCutcheon	NULL
M	NULL
,	NULL
Crabtree	NULL
GR	NULL
,	NULL
Herzenberg	NULL
LA	NULL
:	NULL
The	NULL
actions	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
suggest	NULL
a	NULL
novel	NULL
step	NULL
in	NULL
the	NULL
activation	NULL
of	NULL
T	NULL
lymphocytes	NULL
.	NULL

EMBO	NULL
J	NULL
9:4425	NULL
,	NULL
1990	NULL
4	NULL
.	NULL

Nolan	NULL
GP	NULL
:	NULL
NF-AT-AP-1	NULL
and	NULL
Rel-bZIP	NULL
:	NULL
hybrid	NULL
vigor	NULL
and	NULL
binding	NULL
under	NULL
the	NULL
influence	NULL
.	NULL

Cell	NULL
77:795	NULL
,	NULL
1994	NULL
5	NULL
.	NULL

Rao	NULL
A	NULL
:	NULL
NF-ATp	NULL
:	NULL
A	NULL
transcription	NULL
factor	NULL
required	NULL
for	NULL
the	NULL
coordinate	NULL
induction	NULL
of	NULL
several	NULL
cytokine	NULL
genes	NULL
.	NULL

Immunol	NULL
Today	NULL
15:274	NULL
,	NULL
1994	NULL
6	NULL
.	NULL

Schreiber	NULL
SL	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
The	NULL
mechanism	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
.	NULL

Immunol	NULL
Today	NULL
13:136	NULL
,	NULL
1992	NULL
7	NULL
.	NULL

Shaw	NULL
JP	NULL
,	NULL
Utz	NULL
PJ	NULL
,	NULL
Durand	NULL
DB	NULL
,	NULL
Toole	NULL
JJ	NULL
,	NULL
Emmel	NULL
EA	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Identification	NULL
of	NULL
a	NULL
putative	NULL
regulator	NULL
of	NULL
early	NULL
T	NULL
cell	NULL
activation	NULL
genes	NULL
.	NULL

Science	NULL
241:202	NULL
,	NULL
1988	NULL
8	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Shannon	NULL
MF	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor/interleukin	NULL
3	NULL
locus	NULL
is	NULL
regulated	NULL
by	NULL
an	NULL
inducible	NULL
cyclosporin	NULL
A	NULL
sensitive	NULL
enhancer	NULL
.	NULL

Proc	NULL
Natl	NULL
Acad	NULL
Sci	NULL
USA	NULL
90:2466	NULL
,	NULL
1993	NULL
9	NULL
.	NULL

Cockerill	NULL
PN	NULL
,	NULL
Bert	NULL
AG	NULL
,	NULL
Jenkins	NULL
F	NULL
,	NULL
Ryan	NULL
GR	NULL
,	NULL
Shannon	NULL
MF	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Human	NULL
granulocyte-macrophage	NULL
colony	NULL
-stimulating	NULL
factor	NULL
enhancer	NULL
function	NULL
is	NULL
associated	NULL
with	NULL
cooperative	NULL
interactions	NULL
between	NULL
AP-1	NULL
and	NULL
NFATp/c	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
15:2071	NULL
,	NULL
1995	NULL
10	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
McCaffrey	NULL
PG	NULL
,	NULL
Miner	NULL
Z	NULL
,	NULL
Kerpola	NULL
TK	NULL
,	NULL
Lambert	NULL
TN	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
The	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
is	NULL
a	NULL
substrate	NULL
for	NULL
calcineurin	NULL
and	NULL
interacts	NULL
with	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
365:352	NULL
,	NULL
1993	NULL
11	NULL
.	NULL

Jain	NULL
J	NULL
,	NULL
McCaffrey	NULL
PG	NULL
,	NULL
Valge-Archer	NULL
VE	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fos	NULL
and	NULL
Jun	NULL
.	NULL

Nature	NULL
356:801	NULL
,	NULL
1992	NULL
12	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Luo	NULL
C	NULL
,	NULL
Kerppola	NULL
TK	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Badalian	NULL
TM	NULL
,	NULL
Ho	NULL
AM	NULL
,	NULL
Burgeon	NULL
E	NULL
,	NULL
Lane	NULL
WS	NULL
,	NULL
Lambert	NULL
JS	NULL
,	NULL
Curran	NULL
T	NULL
,	NULL
Verdine	NULL
GL	NULL
,	NULL
Rao	NULL
A	NULL
,	NULL
Hogan	NULL
PG	NULL
:	NULL
Isolation	NULL
of	NULL
the	NULL
cyclosporin-sensitive	NULL
T	NULL
cell	NULL
transcription	NULL
factor	NULL
NFATp	NULL
.	NULL

Science	NULL
262:750	NULL
,	NULL
1993	NULL
13	NULL
.	NULL

Northrop	NULL
JP	NULL
,	NULL
Ho	NULL
SN	NULL
,	NULL
Chen	NULL
L	NULL
,	NULL
Thomas	NULL
DJ	NULL
,	NULL
Timmerman	NULL
LA	NULL
,	NULL
Nolan	NULL
GP	NULL
,	NULL
Admon	NULL
A	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
;	NULL
NF-AT	NULL
components	NULL
define	NULL
a	NULL
family	NULL
of	NULL
transcription	NULL
factors	NULL
targeted	NULL
in	NULL
T-cell	NULL
activation	NULL
.	NULL

Nature	NULL
369:497	NULL
,	NULL
1994	NULL
14	NULL
.	NULL

Northrop	NULL
JP	NULL
,	NULL
Ullman	NULL
KS	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Characterization	NULL
of	NULL
the	NULL
nuclear	NULL
and	NULL
cytoplasmic	NULL
components	NULL
of	NULL
the	NULL
lymphoid-specific	NULL
nuclear	NULL
factor	NULL
of	NULL
activated	NULL
T	NULL
cells	NULL
(	NULL
NF-AT	NULL
)	NULL
complex	NULL
.	NULL

J	NULL
Biol	NULL
Chem	NULL
268:2917	NULL
,	NULL
1993	NULL
15	NULL
.	NULL

Boise	NULL
LH	NULL
,	NULL
Petryniak	NULL
B	NULL
,	NULL
Mao	NULL
X	NULL
,	NULL
June	NULL
CH	NULL
,	NULL
Wang	NULL
CY	NULL
,	NULL
Lindsten	NULL
T	NULL
,	NULL
Bravo	NULL
R	NULL
,	NULL
Kovary	NULL
R	NULL
,	NULL
Leiden	NULL
JM	NULL
,	NULL
Thompson	NULL
JB	NULL
:	NULL
The	NULL
NFAT-1	NULL
DNA	NULL
binding	NULL
complex	NULL
in	NULL
activated	NULL
T	NULL
cells	NULL
contains	NULL
Fra-1	NULL
and	NULL
JunB	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:1911	NULL
,	NULL
1993	NULL
16	NULL
.	NULL

Clipstone	NULL
NA	NULL
,	NULL
Crabtree	NULL
GR	NULL
:	NULL
Identification	NULL
of	NULL
calcineurin	NULL
as	NULL
a	NULL
key	NULL
signalling	NULL
enzyme	NULL
in	NULL
T-lymphocyte	NULL
activation	NULL
.	NULL

Nature	NULL
357:695	NULL
,	NULL
1992	NULL
2697	NULL
17	NULL
.	NULL

O'Keefe	NULL
SJ	NULL
,	NULL
Tamura	NULL
J	NULL
,	NULL
Kincaid	NULL
RL	NULL
,	NULL
Tocci	NULL
MJ	NULL
,	NULL
O'Neill	NULL
EA	NULL
:	NULL
FK-506-	NULL
and	NULL
CsA-sensitive	NULL
activation	NULL
of	NULL
the	NULL
interleukin-2	NULL
promoter	NULL
by	NULL
calcineurin	NULL
.	NULL

Nature	NULL
357:692	NULL
,	NULL
1992	NULL
18	NULL
.	NULL

Masuda	NULL
ES	NULL
,	NULL
Tokumitsu	NULL
H	NULL
,	NULL
Tsubio	NULL
A	NULL
,	NULL
Shlomai	NULL
J	NULL
,	NULL
Hung	NULL
P	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
The	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
cis-acting	NULL
element	NULL
CLEO	NULL
mediates	NULL
induction	NULL
signals	NULL
in	NULL
T	NULL
cells	NULL
and	NULL
is	NULL
recognised	NULL
by	NULL
factors	NULL
related	NULL
to	NULL
API	NULL
and	NULL
NFAT	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
13:7399	NULL
,	NULL
1993	NULL
19	NULL
.	NULL

Tsubio	NULL
A	NULL
,	NULL
Muramatsu	NULL
M	NULL
,	NULL
Tsutsumi	NULL
A	NULL
,	NULL
Arai	NULL
K	NULL
,	NULL
Arai	NULL
N	NULL
:	NULL
Calcineurin	NULL
activates	NULL
transcription	NULL
from	NULL
the	NULL
GM-CSF	NULL
promoter	NULL
in	NULL
synergy	NULL
with	NULL
either	NULL
protein	NULL
kinase	NULL
C	NULL
or	NULL
NF-	NULL
«	NULL
B/AP-1	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

Biochem	NULL
Biophys	NULL
Res	NULL
Commun	NULL
199:1064	NULL
,	NULL
1994	NULL
20	NULL
.	NULL

Jenkins	NULL
F	NULL
,	NULL
Cockerill	NULL
PN	NULL
,	NULL
Bohman	NULL
D	NULL
,	NULL
Shannon	NULL
MF	NULL
:	NULL
Multiple	NULL
signals	NULL
are	NULL
required	NULL
for	NULL
function	NULL
of	NULL
the	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
gene	NULL
promoter	NULL
in	NULL
T	NULL
cells	NULL
.	NULL

J	NULL
Immunol	NULL
155:1240	NULL
,	NULL
1995	NULL
21	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Jain	NULL
J	NULL
,	NULL
Jamieson	NULL
C	NULL
,	NULL
Sen	NULL
R	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
A	NULL
T	NULL
cell	NULL
nuclear	NULL
factor	NULL
resembling	NULL
NF-AT	NULL
binds	NULL
to	NULL
an	NULL
NF-	NULL
«	NULL
B	NULL
site	NULL
and	NULL
to	NULL
the	NULL
conserved	NULL
lymphokine	NULL
promoter	NULL
sequence	NULL
``	NULL
'cytokine-1	NULL
.	NULL
``	NULL

J	NULL
Biol	NULL
Chem	NULL
267:1864	NULL
,	NULL
1992	NULL
22	NULL
.	NULL

Gasson	NULL
JC	NULL
:	NULL
Molecular	NULL
physiology	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
.	NULL

Blood	NULL
77:1131	NULL
,	NULL
1991	NULL
23	NULL
.	NULL

Bevilacqua	NULL
MP	NULL
:	NULL
Endothelial-leukocyte	NULL
adhesion	NULL
molecules	NULL
.	NULL

Annu	NULL
Rev	NULL
Immunol	NULL
11:767	NULL
,	NULL
1993	NULL
24	NULL
.	NULL

Springer	NULL
TA	NULL
:	NULL
Traffic	NULL
signals	NULL
for	NULL
lymphocyte	NULL
recirculation	NULL
and	NULL
leukocyte	NULL
emigration	NULL
:	NULL
the	NULL
multistep	NULL
paradigm	NULL
.	NULL

Cell	NULL
76:301	NULL
,	NULL
1994	NULL
25	NULL
.	NULL

Lopez	NULL
AF	NULL
,	NULL
Williamson	NULL
DJ	NULL
,	NULL
Gamble	NULL
JR	NULL
,	NULL
Begley	NULL
CG	NULL
,	NULL
Harlan	NULL
JM	NULL
,	NULL
Klebanoff	NULL
SJ	NULL
,	NULL
Waltersdorph	NULL
A	NULL
,	NULL
Wong	NULL
G	NULL
,	NULL
Clark	NULL
SC	NULL
,	NULL
Vadas	NULL
MA	NULL
:	NULL
Recombinant	NULL
human	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
(	NULL
rH	NULL
GM-CSF	NULL
)	NULL
stimulates	NULL
in	NULL
vitro	NULL
mature	NULL
human	NULL
neutrophil	NULL
and	NULL
eosinophil	NULL
function	NULL
,	NULL
surface	NULL
receptor	NULL
expression	NULL
and	NULL
survival	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
78:1220	NULL
,	NULL
1986	NULL
26	NULL
.	NULL

Arend	NULL
WP	NULL
,	NULL
Dayer	NULL
JM	NULL
:	NULL
Cytokines	NULL
and	NULL
cytokine	NULL
inhibitors	NULL
or	NULL
antagonists	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
.	NULL

Arthritis	NULL
Rheum	NULL
33:305	NULL
,	NULL
1990	NULL
27	NULL
.	NULL

Calderon	NULL
E	NULL
,	NULL
Lockey	NULL
RF	NULL
,	NULL
Bukantz	NULL
SC	NULL
,	NULL
Coffey	NULL
RG	NULL
,	NULL
Ledford	NULL
DK	NULL
:	NULL
Is	NULL
there	NULL
a	NULL
role	NULL
for	NULL
cyclosporine	NULL
in	NULL
asthma	NULL
?	NULL

J	NULL
Allergy	NULL
Clin	NULL
Immunol	NULL
89:629	NULL
,	NULL
1992	NULL
28	NULL
.	NULL

Wong	NULL
RL	NULL
,	NULL
Winslow	NULL
CM	NULL
,	NULL
Cooper	NULL
KD	NULL
:	NULL
The	NULL
mechanisms	NULL
of	NULL
action	NULL
of	NULL
cyclosporin	NULL
A	NULL
in	NULL
the	NULL
treatment	NULL
of	NULL
psoriasis	NULL
.	NULL

Immunol	NULL
Today	NULL
14:69	NULL
,	NULL
1993	NULL
29	NULL
.	NULL

Kaushansky	NULL
K	NULL
:	NULL
Control	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
production	NULL
in	NULL
normal	NULL
endothelial	NULL
cells	NULL
by	NULL
positive	NULL
and	NULL
negative	NULL
regulatory	NULL
elements	NULL
.	NULL

J	NULL
Immunol	NULL
143:2525	NULL
,	NULL
1989	NULL
30	NULL
.	NULL

Luscinskas	NULL
FW	NULL
,	NULL
Ding	NULL
H	NULL
,	NULL
Lichtman	NULL
AH	NULL
:	NULL
P-selectin	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule	NULL
1	NULL
mediate	NULL
rolling	NULL
and	NULL
arrest	NULL
,	NULL
respectively	NULL
,	NULL
of	NULL
CD4+	NULL
T	NULL
lymphocytes	NULL
on	NULL
tumour	NULL
necrosis	NULL
factor	NULL
-activated	NULL
vascular	NULL
endothelium	NULL
under	NULL
flow	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
181:1179	NULL
,	NULL
1995	NULL
31	NULL
.	NULL

Montefort	NULL
S	NULL
,	NULL
Gratziou	NULL
C	NULL
,	NULL
Goulding	NULL
D	NULL
,	NULL
Polosa	NULL
R	NULL
,	NULL
Haskard	NULL
DO	NULL
,	NULL
Howarth	NULL
PH	NULL
,	NULL
Holgate	NULL
ST	NULL
,	NULL
Carroll	NULL
MP	NULL
:	NULL
Bronchial	NULL
biopsy	NULL
evidence	NULL
for	NULL
leukocyte	NULL
infiltration	NULL
and	NULL
upregulation	NULL
and	NULL
leukocyte-endothelial	NULL
cell	NULL
adhesion	NULL
molecules	NULL
6	NULL
hours	NULL
local	NULL
allergen	NULL
challenge	NULL
of	NULL
sensitised	NULL
asthmatic	NULL
airways	NULL
.	NULL

J	NULL
Clin	NULL
Invest	NULL
93:1411	NULL
,	NULL
1994	NULL
32	NULL
.	NULL

Koch	NULL
AE	NULL
,	NULL
Burrows	NULL
AE	NULL
,	NULL
Haines	NULL
GK	NULL
,	NULL
Carlos	NULL
TM	NULL
,	NULL
Harlan	NULL
JM	NULL
:	NULL
Immunolocalisation	NULL
of	NULL
endothelial	NULL
and	NULL
leukocyte	NULL
adhesion	NULL
molecules	NULL
in	NULL
rheumatoid	NULL
and	NULL
osteoarthritic	NULL
synovial	NULL
tissues	NULL
.	NULL

Lab	NULL
Invest	NULL
64:313	NULL
,	NULL
1991	NULL
33	NULL
.	NULL

Wakita	NULL
H	NULL
,	NULL
Takigawa	NULL
M	NULL
:	NULL
E-selectin	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-	NULL
]	NULL
are	NULL
critical	NULL
for	NULL
initial	NULL
trafficking	NULL
of	NULL
helper/inducer/mem-ory	NULL
T	NULL
cells	NULL
in	NULL
psoriatic	NULL
lesions	NULL
.	NULL

Arch	NULL
Dermatol	NULL
130:457	NULL
,	NULL
1994	NULL
34	NULL
.	NULL

Sartor	NULL
RB	NULL
:	NULL
Cyclosporine	NULL
therapy	NULL
for	NULL
inflammatory	NULL
bowel	NULL
dis-ease	NULL
.	NULL

N	NULL
Engl	NULL
J	NULL
Med	NULL
330:1897	NULL
,	NULL
1994	NULL
35	NULL
.	NULL

Wells	NULL
G	NULL
,	NULL
Tugwell	NULL
P	NULL
:	NULL
Cyclosporin	NULL
A	NULL
in	NULL
rheumatoid	NULL
arthritis	NULL
:	NULL
Overview	NULL
of	NULL
efficacy	NULL
.	NULL

Br	NULL
J	NULL
Rheumatol	NULL
32:51	NULL
,	NULL
1993	NULL
36	NULL
.	NULL

Cockerill	NULL
GW	NULL
,	NULL
Meyer	NULL
G	NULL
,	NULL
Noack	NULL
L	NULL
,	NULL
Vadas	NULL
MA	NULL
,	NULL
Gamble	NULL
JR	NULL
:	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

2698	NULL
Characterisation	NULL
of	NULL
a	NULL
spontaneously	NULL
transformed	NULL
human	NULL
endothelial	NULL
cell	NULL
line	NULL
.	NULL

Lab	NULL
Invest	NULL
71:497	NULL
,	NULL
1994	NULL
37	NULL
.	NULL

Himes	NULL
SR	NULL
,	NULL
Coles	NULL
LS	NULL
,	NULL
Katsikeros	NULL
R	NULL
,	NULL
Lang	NULL
RK	NULL
,	NULL
Shannon	NULL
MF	NULL
:	NULL
HTLV-1	NULL
tax	NULL
activation	NULL
of	NULL
the	NULL
GM-CSF	NULL
and	NULL
G-CSF	NULL
promoters	NULL
requires	NULL
the	NULL
interaction	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
with	NULL
other	NULL
transcription	NULL
factor	NULL
fami-lies	NULL
.	NULL

Oncogene	NULL
8:3189	NULL
,	NULL
1993	NULL
38	NULL
.	NULL

Dunn	NULL
SM	NULL
,	NULL
Coles	NULL
LS	NULL
,	NULL
Lang	NULL
RK	NULL
,	NULL
Gerondakis	NULL
S	NULL
,	NULL
Vadas	NULL
MA	NULL
,	NULL
Shannon	NULL
MF	NULL
:	NULL
Requirement	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
p65	NULL
and	NULL
NF-interleukin-6	NULL
binding	NULL
elements	NULL
in	NULL
the	NULL
tumour	NULL
necrosis	NULL
factor	NULL
response	NULL
region	NULL
of	NULL
the	NULL
granulocyte	NULL
colony-stimulating	NULL
factor	NULL
promoter	NULL
.	NULL

Blood	NULL
83:2469	NULL
,	NULL
1994	NULL
39	NULL
.	NULL

Pober	NULL
JS	NULL
,	NULL
Slowik	NULL
MR	NULL
,	NULL
De	NULL
Luca	NULL
LG	NULL
,	NULL
Ritchie	NULL
AJ	NULL
:	NULL
Elevated	NULL
cyclic	NULL
AMP	NULL
inhibits	NULL
endothelial	NULL
cell	NULL
synthesis	NULL
and	NULL
expression	NULL
of	NULL
TNF-induced	NULL
endothelial	NULL
leukocyte	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
and	NULL
vascular	NULL
cell	NULL
adhesion	NULL
molecule-1	NULL
,	NULL
but	NULL
not	NULL
intercellular	NULL
adhesion	NULL
molecule-1	NULL
.	NULL

J	NULL
Immunol	NULL
150:5114	NULL
,	NULL
1993	NULL
40	NULL
.	NULL

Schindler	NULL
U	NULL
,	NULL
Baichwal	NULL
VR	NULL
:	NULL
Three	NULL
NF-KB	NULL
binding	NULL
sites	NULL
in	NULL
the	NULL
human	NULL
E-selectin	NULL
gene	NULL
required	NULL
for	NULL
maximal	NULL
tumour	NULL
necrosis	NULL
factor	NULL
alpha-induced	NULL
expression	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:5820	NULL
,	NULL
1994	NULL
41	NULL
.	NULL

Lewis	NULL
H	NULL
,	NULL
Kaszubska	NULL
W	NULL
,	NULL
DeLarmarter	NULL
JF	NULL
,	NULL
Whelan	NULL
J	NULL
:	NULL
Coopera-tivity	NULL
between	NULL
two	NULL
NF-kB	NULL
complexes	NULL
,	NULL
mediated	NULL
by	NULL
high	NULL
mobility	NULL
group	NULL
protein	NULL
I	NULL
(	NULL
Y	NULL
)	NULL
,	NULL
is	NULL
essential	NULL
for	NULL
cytokine	NULL
induced	NULL
expression	NULL
of	NULL
the	NULL
E-selectin	NULL
promoter	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:5701	NULL
,	NULL
1994	NULL
42	NULL
.	NULL

Whitely	NULL
MZ	NULL
,	NULL
Thanos	NULL
D	NULL
,	NULL
Read	NULL
MA	NULL
,	NULL
Maniatis	NULL
T	NULL
,	NULL
Collins	NULL
T	NULL
:	NULL
A	NULL
COCKERILL	NULL
ET	NULL
AL	NULL
striking	NULL
similarity	NULL
in	NULL
the	NULL
organisation	NULL
of	NULL
the	NULL
E-selectin	NULL
and	NULL
beta	NULL
interferon	NULL
gene	NULL
promoters	NULL
.	NULL

Mol	NULL
Cell	NULL
Biol	NULL
14:6464	NULL
,	NULL
1994	NULL
43	NULL
.	NULL

McCaffrey	NULL
PG	NULL
,	NULL
Kim	NULL
PK	NULL
,	NULL
Valge-Archer	NULL
VE	NULL
,	NULL
Sen	NULL
R	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Cyclosporin	NULL
A	NULL
sensitivity	NULL
of	NULL
the	NULL
NF-KB	NULL
site	NULL
of	NULL
the	NULL
IL2Ra	NULL
promoter	NULL
in	NULL
untransformed	NULL
murine	NULL
T	NULL
cells	NULL
.	NULL

Nucleic	NULL
Acids	NULL
Res	NULL
22:2134	NULL
,	NULL
1994	NULL
44	NULL
.	NULL

Venkataraman	NULL
L	NULL
,	NULL
Burakoff	NULL
SJ	NULL
,	NULL
Sen	NULL
R	NULL
:	NULL
FK506	NULL
inhibits	NULL
antigen	NULL
receptor-mediated	NULL
induction	NULL
of	NULL
c-rel	NULL
in	NULL
B	NULL
and	NULL
T	NULL
lymphoid	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
181:1091	NULL
,	NULL
1995	NULL
45	NULL
.	NULL

Goldfeld	NULL
AE	NULL
,	NULL
Tsai	NULL
E	NULL
,	NULL
Kincaid	NULL
R	NULL
,	NULL
Beelshaw	NULL
PJ	NULL
,	NULL
Schreiber	NULL
SL	NULL
,	NULL
Strominger	NULL
JL	NULL
,	NULL
Rao	NULL
A	NULL
:	NULL
Calcineurin	NULL
mediates	NULL
human	NULL
tumour	NULL
necrosis	NULL
factor	NULL
a	NULL
gene	NULL
induction	NULL
in	NULL
stimulated	NULL
T	NULL
and	NULL
B	NULL
cells	NULL
.	NULL

J	NULL
Exp	NULL
Med	NULL
180:763	NULL
,	NULL
1994	NULL
46	NULL
.	NULL

Choi	NULL
MSK	NULL
,	NULL
Brines	NULL
RD	NULL
,	NULL
Holman	NULL
MJ	NULL
,	NULL
Klaus	NULL
GGB	NULL
:	NULL
Induction	NULL
of	NULL
NF-AT	NULL
in	NULL
normal	NULL
B	NULL
lymphocytes	NULL
by	NULL
anti-immunoglobulin	NULL
or	NULL
CD40	NULL
ligand	NULL
in	NULL
conjunction	NULL
with	NULL
IL-4	NULL
.	NULL

Immunity	NULL
1:179	NULL
,	NULL
1994	NULL
47	NULL
.	NULL

Venkataraman	NULL
L	NULL
,	NULL
Francis	NULL
DA	NULL
,	NULL
Wang	NULL
Z	NULL
,	NULL
Liu	NULL
J	NULL
,	NULL
Rothstein	NULL
TL	NULL
,	NULL
Sen	NULL
R	NULL
:	NULL
Cyclosporin-A	NULL
sensitive	NULL
induction	NULL
of	NULL
NF-AT	NULL
in	NULL
murine	NULL
B	NULL
cells	NULL
.	NULL

Immunity	NULL
1:189	NULL
,	NULL
1994	NULL
48	NULL
.	NULL

Ten	NULL
RM	NULL
,	NULL
Paya	NULL
CV	NULL
,	NULL
Israel	NULL
N	NULL
,	NULL
Le	NULL
Bail	NULL
O	NULL
,	NULL
Mattei	NULL
MG	NULL
,	NULL
Virilizier	NULL
JL	NULL
,	NULL
Kourilsky	NULL
P	NULL
,	NULL
Israel	NULL
A	NULL
:	NULL
The	NULL
characterization	NULL
of	NULL
the	NULL
promoter	NULL
of	NULL
the	NULL
gene	NULL
encoding	NULL
the	NULL
p50	NULL
subunit	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
indicates	NULL
that	NULL
it	NULL
participates	NULL
in	NULL
its	NULL
own	NULL
regulation	NULL
.	NULL

EMBO	NULL
J	NULL
11:195	NULL
,	NULL
1993	NULL
49	NULL
.	NULL

Norris	NULL
AA	NULL
,	NULL
Jackson	NULL
DM	NULL
,	NULL
Eady	NULL
RP	NULL
:	NULL
Protective	NULL
effects	NULL
of	NULL
cy-clophosphamide	NULL
,	NULL
cyclosporin	NULL
A	NULL
and	NULL
FK506	NULL
against	NULL
antigen-induced	NULL
lung	NULL
eosinophilia	NULL
in	NULL
guinea	NULL
pigs	NULL
.	NULL

Clin	NULL
Exp	NULL
Immunol	NULL
89:347	NULL
,	NULL
1992	NULL
From	NULL
www.bloodjournal.org	NULL
by	NULL
guest	NULL
on	NULL
May	NULL
10	NULL
,	NULL
2019	NULL
.	NULL

For	NULL
personal	NULL
use	NULL
only	NULL
.	NULL

®	NULL
blO	NULL
0d	NULL
1995	NULL
86	NULL
:	NULL
2689-2698	NULL
Regulation	NULL
of	NULL
granulocyte-macrophage	NULL
colony-stimulating	NULL
factor	NULL
and	NULL
E-	NULL
selectin	NULL
expression	NULL
in	NULL
endothelial	NULL
cells	NULL
by	NULL
cyclosporin	NULL
A	NULL
and	NULL
the	NULL
T-cell	NULL
transcription	NULL
factor	NULL
NFAT	NULL
GW	NULL
Cockerill	NULL
,	NULL
AG	NULL
Bert	NULL
,	NULL
GR	NULL
Ryan	NULL
,	NULL
JR	NULL
Gamble	NULL
,	NULL
MA	NULL
Vadas	NULL
and	NULL
PN	NULL
Cockerill	NULL
A	NULL
_	NULL
48	NULL
o	NULL
6	NULL
'	NULL
t	NULL
“	NULL
f.9	NULL
'	NULL
.	NULL
'	NULL

e	NULL
>	NULL
\	NULL
/	NULL
{	NULL
®	NULL
Updated	NULL
information	NULL
and	NULL
services	NULL
can	NULL
be	NULL
found	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/content/86/7/2689.full.html	NULL
Articles	NULL
on	NULL
similar	NULL
topics	NULL
can	NULL
be	NULL
found	NULL
in	NULL
the	NULL
following	NULL
Blood	NULL
collections	NULL
Information	NULL
about	NULL
reproducing	NULL
this	NULL
article	NULL
in	NULL
parts	NULL
or	NULL
in	NULL
its	NULL
entirety	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
requests	NULL
Information	NULL
about	NULL
ordering	NULL
reprints	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/misc/rights.xhtml	NULL
#	NULL
reprints	NULL
Information	NULL
about	NULL
subscriptions	NULL
and	NULL
ASH	NULL
membership	NULL
may	NULL
be	NULL
found	NULL
online	NULL
at	NULL
:	NULL
http	NULL
:	NULL
//www.bloodjournal.org/site/subscriptions/index.xhtml	NULL
Blood	NULL
(	NULL
print	NULL
ISSN	NULL
0006-4971	NULL
,	NULL
online	NULL
ISSN	NULL
1528-0020	NULL
)	NULL
,	NULL
is	NULL
published	NULL
weekly	NULL
by	NULL
the	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
,	NULL
2021	NULL
L	NULL
St	NULL
,	NULL
NW	NULL
,	NULL
Suite	NULL
900	NULL
,	NULL
Washington	NULL
DC	NULL
20036	NULL
.	NULL

Copyright	NULL
2011	NULL
by	NULL
The	NULL
American	NULL
Society	NULL
of	NULL
Hematology	NULL
;	NULL
all	NULL
rights	NULL
reserved	NULL
.	NULL

